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ABSTRACT
The goal of the research presented in this dissertation is to develop iron nanoparticles suitable for
use as Magnetic Resonance Imaging (MRI) contrast agents, for enhancement of Laser Induced
Thermal Therapy (LITT), and to combine these capabilities for Magnetic Resonance guided
Laser Induced Thermal Therapy (MRgLITT). In order to accomplish this, small metallic iron
nanoparticles were to be produced with a biocompatible coating. Synthesis methods employed
are reduction and thermal decomposition of iron (ii) chloride, iron pentacarbonyl, and iron
sulfate. Several biocompatible coatings were investigated to determine their performance as a
protective layer. Characterization techniques used include DLS, TEM, Mössbauer Spectroscopy,
NMR, and cytotoxicity.
Reduction of iron (ii) chloride resulted in metal iron and iron oxide nanoparticles. Iron metal
nanoparticles had not oxidized completely after three years of storage in air. Thermal
decomposition of iron pentacarbonyl in organics produced iron oxide nanoparticles with an iron
metal core. The reaction proved to be very reproducible. Iron sulfate reductions created metal
and amorphous iron nanoparticles.
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CHAPTER I
INTRODUCTION
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The aim of this research is to develop iron nanoparticles suitable for use as MRI contrast agents,
for enhancement of LITT, and to combine these capabilities for MRgLITT. Synthesis methods
employed are reduction and thermal decomposition of various iron reactants. Several
biocompatible coatings were investigated to determine their performance as a protective layer.
Characterization techniques used include DLS, TEM, Mössbauer Spectroscopy, NMR, and
cytotoxicity. The main target of this biomedical application is to further the diagnosis and
treatment of brain cancer, specifically glioblastoma multiforme.

Magnetic Resonance Imaging
Nanoparticles containing iron, including metallic iron (Fe), maghemite (γ-Fe3O4) and magnetite
(Fe3O4), are being heavily researched for their applications in medicine, including magnetic
hyperthermia and Magnetic Resonance Imaging (MRI) (Pinsanic). Iron nanoparticle contrast
agents offer improvement to current MRI technologies and can be used in combination with
hyperthermia therapies to precisely treat tumors. Image-guided hyperthermia treatments have been
shown to be an efficient diagnostic and therapeutic tool in recent oncology clinical trials (Lewin).
MRI contrast agents are fast-relaxing superparamagnets which shorten the relaxation time of
surrounding protons. They typically reduce T2 and T2*-weighted relaxation times resulting in a
negative contrast. This spin-spin relaxation is due to induced local field inhomogeneities and is
described by relaxivity R2 (1/T2). The relaxivity of the particles is associated with their magnetic
susceptibility as a function of particle size and composition (Qiao). Metallic iron has the highest
room-temperature magnetic susceptibility of any element, giving it the strongest response to an
applied field (Huber). Along with a low magneto-crystalline anisotropy, metallic iron has more
magnetism per unit volume than nickel, cobalt or its oxide counterpart. It also exhibits a greater
magnetic moment than any other metal (Huber).
Induced hyperthermia for cancer treatment is another significant contribution magnetic
nanoparticles can make to medicine. They are introduced directly at the tumor or through systemic
injection. The high magnetic saturation of the nanoparticles would allow them to absorb energy
from an alternating magnetic field and convert it to heat through hysteresis losses or Néel
relaxation (Laurent). The hypoxic environment of tumor cells cause them to be more sensitive to
2

heat than normal cells (Rahmathulla). This allows the tumor to be eliminated with minimal
collateral damage to surrounding tissue (Hafeli).
Since nanophase toxicity is widely disputed, it is extremely important to test the iron nanoparticles
thoroughly before putting them into use (Yu). The nanoparticle medium must be biocompatible to
serve as a viable hyperthermia or MRI contrast agent. Producing metallic iron nanoparticles in a
form that can be used in biomedical applications is challenging due to the risk of oxidation in
biocompatible solvents (Reddy).
Previous researchers have successfully made metallic iron nanoparticles, but they were embedded
in layers, such as graphene oxide sheets (Tucek) and polymer layers (Mørup) or onto surfaces
(Christensen). For clinical use, it is necessary to make free, metallic iron particles which can be
made into a suspension for injection into a patient’s blood stream.
To achieve MRI contrast, materials must have high saturation magnetization (Hofmann). Metallic
iron has a much greater saturation magnetization (0Ms = 2.16 T) than iron oxide (0.54 T) and
would allow for less contrast medium to be used while achieving better resolution (Coey). Hence
iron is a highly attractive option of nanoparticles for medical applications and is the subject of this
dissertation.
Another important characteristic is size as size affects magnetic moment and the response magnetic
nanoparticles have to external magnetic fields. A decreased MNP size will cause a faster relaxation
time, which will increase their heating rate. This increased heating rate will make smaller sized
nanoparticles more efficient as an MRI contrast agent and hyperthermia therapy (Reddy).

Laser Induced Thermal Therapy
In recent years, development of nanomaterials for medical applications has been a major focus
amongst scientists. Magnetic nanoparticles (MNPs) are a subset of nanoparticles (particulate
material of size < 100 nm) able to be directed under the influence of a magnetic field. These
magnetic properties are desirable for their potential applications in magnetic resonance imaging
(MRI), hyperthermia therapies, and drug delivery (Shubayev, Wu).
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In using Laser-induced Thermal Therapy (LITT) as a hyperthermia treatment of cancer, localized
photo-thermal heating will cause tumor tissue to reach coagulation temperatures while sparing
healthy tissue (Carpentier). Superparamagnetic MNPs will absorb energy from a near-infrared
laser and convert it to heat. Because tumor tissue is more susceptible to heat than healthy tissue,
this can be used to destroy the tumor (Laurent).
Size affects the magnetic moment and response MNPs have to external magnetic fields. A decrease
in size of MNPs will result in a faster relaxation time, which would increase their heating rate and
make them more efficient as hyperthermia therapies or MRI contrast agents. Particle size has been
known to influence the signal (T2/T1) in MRI (Reddy).
Size also affects the biocompatibility of MNPs. Clearance of MNPs through the reticuloendothelial
system is much slower with smaller particles. MNPs > 200 nm may become trapped in the spleen.
In addition, uptake by the liver increases with size. MNPs larger than 10 nm have great difficulty
penetrating cell walls (Reddy). For ideal heating properties and biocompatibility, it is important to
synthesize iron nanoparticles < 10 nm.
Monometallic nanoparticles suffer from increased reactivity due to their large surface-to-volume
ratio (Huber). If left in air, MNPs quickly oxidize, causing an undesirable decrease in magnetic
susceptibility. Uncoated MNPs are prone to agglomeration attributed to their van der Waals and
magnetic forces (Gupta).
Reactivity and agglomeration can be mitigated through the application of a hydrophilic coating to
the nanoparticle surface. A polymeric material stabilizes the fluid by providing steric repulsion
that acts as a barrier between individual particles, preventing aggregation. Polyethylene glycol
(PEG) is the most popular nanoparticle coating in medicine due to its steric and nontoxic properties
(Reddy). A hydrophilic PEG coating increases resistance to protein adsorption in the blood,
allowing MNPs to experience a longer lifetime in the circulatory system (Illes). Circulation halflife can be amplified from several minutes to hours, sometimes even days, depending on the
hydrophilic coating (Reddy).
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A possible drawback to coating monometallic MNPs is reduced magnetization attributed to nonmagnetic coatings or purposefully oxidized shells (Yoon). An optimal ferrofluid consisting of
monometallic iron nanoparticles must achieve a balance between the desirable magnetic properties
of pure iron and the biocompatibility of a coated MNP. The main goal of this work is to compare
the effect different coatings have on chemical composition, size, and stability of iron nanoparticles
prepared using a thermal decomposition synthesis. Transmission Electron Microscopy (TEM) and
Mössbauer Spectroscopy will be employed to characterize these effects.

Magnetic Resonance guided Laser Induced Thermal Therapy
The aim of this research is to develop a biocompatible nanoparticle that can be safely injected into
humans to improve contrast imaging of T2 weighed MRI, to offer laser induced thermal treatments
for those unable to undergo surgery or as palliative care, and to combine the two techniques to
offer precision in targeting deep seated, hard to reach brain tumors and destroy them via
hyperthermia. This combined technique is Magnetic Resonance guided Laser Induced Thermal
Therapy (MRgLITT).
Magnetic Resonance guided Laser Induced Thermal Therapy (MRgLITT) is a hyperthermia
therapy that uses real time magnetic resonance imaging to plan treatments preoperatively and
monitor ablative therapy intraoperatively. Laser Induced Thermal Therapy (LITT) was
discovered in the 1980s when tissue coagulation of brain tumor models were noted after
exposure to a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser. Other studies
established the feasibility of LITT during this period, but the treatment was shelved due to the
inability to monitor tissue heating rates in real time that lead to tissue vaporization. Progression
of imaging technology has now made intraoperative thermal monitoring possible. In recent years
MRgLITT has resurfaced as an option for treatment of difficult to access and recurrent
glioblastomas (Rahmathulla 2014).
Adding MRgLITT to traditional and current therapies could improve patient survival in an area
that needs improvement. The survival rate of glioblastoma is very low: 5 months for recurrent
GBM and 14 to 16 months for newly diagnosed GBM following resection surgery, radiation
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treatments, and chemotherapy. When progression occurs, there is a 6-month survival rate of just
5-15% (Lee 2016).
At least ten notable clinical trials have been performed using MRgLITT on patients with
glioblastoma multiforme (King Book chapter). A majority of patients evaluated in the clinical
trials had recurrent tumors, chose not to undergo radiation and/or chemotherapy treatments or
were ineligible for traditional surgery. These clinical studies determined MRgLITT to be a
feasible treatment, but suggested clinical trials need to be improved (i.e. larger sample sizes and
randomized studies) in order to validate the efficacy of MRgLITT as a treatment for
glioblastomas. Many of these clinical studies also resulted in suggestions for standard treatment
procedures that could improve MRgLITT’s effectiveness. One consensus among all authors of
the clinical trials was the need to define the optimal role of MRgLITT moving forward as a
treatment.
There are currently two commercially available systems suitable for MRgLITT: NeuroBlate
(Monteris Medical Inc.) and Visualase (Medtronic Inc.). NeuroBlate uses a Nd:YAG laser with a
sapphire, CO2 gas-cooled laser probe. Both a side-firing and diffuse-tip probe are available. The
NeuroBlate system connects to existing MRI systems and uses a thermocouple to provide realtime thermographic data seen in the figure below (Missios 2015, Lee 2016).
Visualase uses a diode laser with a quartz, saline cooled diffusion probe tip. Although
Visualase’s probe is omnidirectional and may not provide as much control as the side-emitting
probe of NeuroBlate’s system, Visualase provides a faster heating rate and can reduce a patient’s
time under anesthesia. The Visualase system estimates then displays damage based on the
Arrhenius model of tissue damage and has the ability to set temperature limits to prevent tissue
vaporization (Lee 2016).
Challenges currently facing MRgLITT include post-treatment edemas and the lack of response to
focal therapies. Edemas and neurological deficits following treatments can affect patient quality
of life. Many of these complications were proven temporary in clinical trials and patients were
restored to pre-treatment or improved neurological function. Glioblastomas are an invasive
6

disease that traditional focal therapies do not adequately address, but due to its aggressive
tentacle nature many therapies have not successfully treated this disease. In some cases, there
may be no other treatment options available (Elder 2013).
The development of magnetic nanoparticles to improve the efficacy of MRgLITT treatments was
suggested in several clinical studies (Norred 2014, Missios 2015). Nanoparticles would increase
the definition of thermal gradients between healthy and tumor tissue (Missios, 2015). This would
aid in sparing critical eloquent structures or tissue that might be damaged due to laser probe
limitations (Rahmathulla, 2014).
Iron containing nanoparticles specifically have been shown to function as both an MR contrast
agent and a heat transducer for LITT. The bi-functionality of these nanoparticles could make
planning MRgLITT treatments more accurate. The exact distribution of the therapeutic agent
could be imaged preoperatively and allow surgeons to adjust trajectories or time as needed to
optimize treatment. This would result in increased ablation accuracy and less thermal damage to
healthy tissue (Ding 2011).
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CHAPTER II
REDUCTION OF IRON CHLORIDE

8

A version of this chapter was originally published by J.E. King et al.:
King JE, Hah HY, Johnson CE, Johnson JA, Pawel MD, et al. (2018) Synthesis of Iron
Nanoparticles for Enhanced MRI Contrast Agents. J Nanosci Adv Tech 2(3): 14-19.
J.E. King wrote the article and performed most of the research. Dr. Gorgio and Dr.
Kirkbride assisted in Cytotoxicity measurements at Vanderbilt University. Dr. Rondinone and
M.D. Pawel provided guidance during synthesis at Oak Ridge National Laboratory. Dr. Hah and
Dr. C. Johnson assisted with Mössbauer spectroscopy. Dr. J. Johnson supervised the work.
Changes have been made to this article for inclusion in this dissertation. The synthesis and
characterization of nine more samples were added. DLS results were added for previously
mentioned and newly added samples. Additional TEM results and Mössbauer Spectroscopy results
were included for all samples.

Introduction
In this chapter, iron metal nanoparticles and superparamagnetic iron oxide nanoparticles were
successfully synthesized. Thirteen samples were created using a reduction method with various
coatings and synthesis techniques. These results were confirmed by Mössbauer Spectroscopy,
Transmission Electron Microscopy (TEM), and Dynamic Light Scattering (DLS). Cell toxicity
was evaluated on one sample to ensure the biocompatibility required for medical applications.

Methods
Iron Nanoparticle Syntheses
A summary of synthesis conditions including type, coating, and solvent can been seen in Table 1.
Synthesis I
Samples JK001-JK007 were synthesized at the Center for Nanophase Materials at Oak Ridge
National Laboratory, Oak Ridge, TN by reacting 2.4 g iron (II) chloride (Sigma Aldrich) and 30
mL pure ethanol (Decon Labs) with 1.2 g sodium borohydride (Sigma Aldrich) and 30 mL
deionized water. The two mixtures were collected into 30 mL syringes and placed in a dual syringe
pump; the pump was set to a rate of 5 mL per minute. The nanoparticles were formed when the
borohydride solution interacted with the chloride solution by reducing it in a nitrogen atmosphere.
For samples JK001, JK003, JK006 and JK007 the reduction reaction continued down the
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Table 1 Summary of synthesis conditions for iron chloride reduction samples
Sample Synthesis Type

Coating

Solvent

JK001

Reduction with syringe pump and separatory funnel into flask

Brij 30

Ethanol

JK002

Reduction with syringe pump into flask

Brij 30

Ethanol

JK003

Reduction with syringe pump and separatory funnel into flask

Brij 30

Ethanol

JK004

Reduction with syringe pump into flask

Brij 30

Ethanol

JK005

Reduction with syringe pump into flask

Brij 30

Ethanol

JK006

Reduction with syringe pump and separatory funnel into flask

Brij 30

Ethanol

JK007

Reduction with syringe pump and separatory funnel into flask

PEG 600 diacid

Ethanol

JK009

Reduction with syringe pump and separatory funnel into flask

none

Ethanol

JK010

Reduction without funnels and syringe pump

Brij 30

Ethanol

JK011

Reduction with syringe pump and separatory funnel into flask

PEG 600 diacid

Ethanol

JK012

Reduction with syringe pump and separatory funnel into flask

PEG 600 diacid

Ethanol

JK018

Reduction with funnels into flask

Brij 30

Ethanol

JK019

Reduction with funnels into flask

Brij 30

Ethanol
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separatory funnel then the side of a round bottom flask and into a stirring coating mixture as seen
in Figure 1 (all figures can be found in the chapter’s Appendix). Samples JK002, JK004, and
JK005 did not utilize the separatory funnel and instead the tubing from the syringe pump fed
directly onto the neck of a round bottom flask, down the side of the flask and into a stirring coating
mixture as seen in Figure 2. The coating mixtures for samples JK001-JK006 consisted of 10 mL
Brij 30 (Sigma Aldrich) and 50 mL ethanol. The coating mixture for sample JK007 consisted of
10 mL polyethylene glycol diacid 600 (Sigma Aldrich) in 50 mL of ethanol. The particles were
stirred at 250 rpm for 30 minutes to break up the agglomerations and sufficiently coat the particles.
Washing and Sample Work-Up

The coated particles were centrifuged at 9000 rpm for 10 minutes and washed with ethanol twice
then transferred to a sample jar and sonicated for 45 minutes to break up agglomerates. After
sonication the particles were magnetically separated using a neodymium magnet below the sample
jar and pipetting off the liquid remaining above the particles.
Synthesis II
Samples JK009-JK012 were synthesized at the University of Tennessee Space Institute in
Tullahoma, TN. Sample JK009 replicated the procedure for Synthesis I with a separatory funnel
using 4.8 g iron (ii) chloride (Sigma Aldrich) in 60 mL of ethanol and 1.2 g sodium borohydride
(Sigma Aldrich) in 30 mL ultrapure water into the Brij 30 (Sigma Aldrich) coating mixture.
Sample JK010 was prepared by slowly pouring 1.2 g sodium borohydride in 30 mL ultrapure water
into 1.2 g iron (ii) chloride in 30 mL ethanol. The reaction was extremely exothermic and released
a lot of gas. The reaction mixture was swirled for 30 seconds to aid mixing then stirred for 5
minutes.
For samples JK011 and JK012 iron reactant and sodium borohydride solutions were prepared by
sonicating 2.4 g iron (ii) chloride with 60 mL ethanol and 2.4 g sodium borohydride with 60 mL
deionized water. 25 mL of each solution was taken up into 30 mL syringes through tubing and
placed in a dual syringe pump; the pump was set to a rate of 8 mL per minute. The nanoparticles
formed by reacting down the side of a separatory funnel and neck of a round bottom flask into 50
mL of a coating mixture as seen in Figure 3. The coating mixture was prepared by stirring 40 mL
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PEG diacid 600 and 200 mL ethanol. Sample JK011 was stopped after 20 mL of the reactant
solutions were dispensed; the sodium borohydride mixture outgassed before the entirety could be
used. For the same reason and due to the pump stalling on five occasions, JK012 was stopped after
17 mL of iron chloride solution had been dispensed. 50 mL and 15 mL of coating solution was
used to rinse the stir bar of particles for JK011 and JK012 respectively.
Washing and Sample Work-Up

Samples JK011 and JK012 were magnetically separated from the reaction solution. Ethanol was
added to rinse the particles followed by magnetic separation of particles from solution; this was
repeated three times. (DLS samples were diluted with ethanol and sonicated. Mössbauer samples
were taken as is after washing).
Synthesis III
Samples JK018 and JK019 were synthesized at the Center for Nanophase Materials at Oak Ridge
National Laboratory, Oak Ridge, TN by reacting 2.4 g iron (II) chloride (Sigma Aldrich) and 30
mL pure ethanol (Decon Labs) with 1.2 g sodium borohydride (Sigma Aldrich) and 30 mL
deionized water. The two mixtures were added to two different separatory funnels. The funnels
were placed so that the ends of the funnels met together on the side of a funnel above a flask as
seen in Figure 4. This was done to provide maximum reaction time and decrease particle size. The
nanoparticles were formed when the borohydride solution interacted with the chloride solution by
reducing it down the sides of the glassware into a coating mixture under argon gas flow. The
coating mixture consisted of 10 mL Brij 30 (Sigma Aldrich) and 50 mL ethanol. The reaction rate
was controlled by adjusting the stoppers of the separatory funnels for each solution. The separatory
funnel containing iron chloride was closed off when the sodium borohydride had outgassed; this
was done to prevent unreacted iron chloride in the product. The particles were stirred at 250 rpm
for 30 minutes to break up the agglomerations and sufficiently coat the particles.
Washing and Sample Work-Up

The coated particles were magnetically separated from the reaction solution. Ethanol was added
to rinse the particles followed by magnetic separation of particles from solution. Samples were
magnetically separated using a neodymium magnet below the sample jar and pipetting off the
liquid remaining above the particles; this was repeated three times. For Sample JK019, 10 mL of
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toluene was added to aid particle suspension in storage.

Characterization
Transmission Electron Microscopy
Transmission electron microscopy (TEM) was performed at the Center for Nanophase Materials
at Oak Ridge National Laboratory, Oak Ridge, TN using a Zeiss Libra 120. Samples were prepared
by diluting the nanoparticles with ethanol until the solution was barely tinted as in Figure 5. A
copper TEM grid was dipped into the solution and dried in air. Samples JK001, JK002, JK003,
JK004, JK005, JK006, JK007, and JK018 were characterized using this technique.
Dynamic Light Scattering
Dynamic Light Scattering (DLS) analysis was performed at the University of Tennessee Space
Institute, Tullahoma, TN using a Particulate Systems NanoPlus Zeta/Nano Particle Analyzer.
Samples were prepared by diluting the nanoparticles with ethanol until the solution was barely
tinted as seen in Figure 6. The diluted solution was pipetted into a quartz cuvette. Analysis was
performed using the NanoPlus software program. Samples JK001, JK002, JK007, JK011 and
JK012 were characterized using this technique.
Cytotoxicity
Cytotoxicity studies were performed at Vanderbilt University, Nashville, TN using varying
concentrations of JK003. Sample JK003 was selected for this experiment because it appeared the
most promising with respect to size from TEM results; ideal diameters are 3-7 nm. Mössbauer
spectroscopy had not been completed at this time but JK003 was later determined to possess
metallic iron.
Luc-231 cells, human breast cancer MDA-MB-231 cells that are stably transfected to
constitutively expressed firefly luciferase, were cultured in DMEM (Gibco, Carlsbad, CV) with
10% FBS (Gibco, Carlsbad, CA) and 50 µg/mL gentamicin (Gibco, Carlsbad, CA). Cells were
isolated by incubation for 5 minutes in 0.05% trypsin. Isolated cells were centrifuged at 1000 rpm
for 5 minutes in conical tubes to separate the cells from the media. The supernatant was discarded
and cells were re-suspended in DMEM. The concentration and viability of cells were assessed
using trypan blue and measured in a hematocytometer shown in Figure 7. Cells were cultured in
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96 well plates with an initial seeding density of 50,000 cells per cm2.
Iron nanoparticles were added to the cells at various dilutions and untreated wells served as
controls. Nanoparticle concentrations were estimated by volume. Nanoparticles were in contact
with cells for 17, 24 or 48 hours prior to the replacement of cell culture medium with DMEM
containing 1:200 luciferin. Plates were imaged using a Xenogen IVIS 200 imaging system and the
luminescence was measured in radiance (photons). Cell growth suppressed by iron nanoparticles
are detected by a reduced luminescence intensity relative to untreated controls in direct proportion
to cell number and metabolism.
Mössbauer Spectroscopy
The Mössbauer Spectroscopy experiments were performed at The University of Tennessee Space
Institute (UTSI), Tullahoma, TN using a
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Co source, a Janis SHI-850-5 cryogen-free cryostat,

Lakeshore 325 Temperature Controller (seen in Figure 8) and Mössbauer GenFit Software (R.S.
Preston and D.E. Brown) for analysis. Samples were prepared by pipetting concentrated
nanoparticle solutions into Mössbauer sample cups made at UTSI. The samples were dried by
allowing the ethanol to evaporate in air; this can be seen in Figure 9. Once dry, a plug was used to
seal the sample cup. Samples JK002, JK003, JK004, JK007, JK011, JK012, JK018, and JK019
were characterized using this technique.
Sample JK002 was characterized at 6 Kelvin (K), 293 K (room temperature), 293 K with a 10
kilogauss (kG) field, and at 6 K two months post synthesis. Sample JK003 was characterized at
6K, 6K with a 0.073 Tesla (T) perpendicular field, 293 K, 293 K with a 10 kG field, 6 K two years
post synthesis, and again at 6 K, 293 K, 293 K with a 10kG and 20 kG field four years post
synthesis. Samples JK004 and JK007 were characterized at 6 K. Sample JK011 was characterized
at 6 K, 293 K, and 293 K with a 10 kG field. Sample JK012 was characterized at 6 K, 180 K, 250
K, 293 K, and 293 K with a 10 kG field. Sample JK018 was characterized at 6 K, 293 K, and 300
K. Sample JK019 was characterized at 6 K, 6 K with a 0.073 T perpendicular and parallel fields,
260 K, 270 K, 293 K, and 293 K with a 10 kG perpendicular field. A summary of these samples
and their experimental conditions can be seen in Table Q alongside their results.
Anhydrous iron (II) chloride reactant used in nanoparticle syntheses was characterized with
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Mössbauer Spectroscopy to compare with sample results, specifically JK011 and JK012. An iron
calibration spectrum was obtained from the Mössbauer Spectrometer to compare with our
synthesized samples. A 57Co source was used for the calibration and sample runs. The chemical
isomer shift of metallic iron is 0 mm/s. The hyperfine field is shown by the distance between the
first and last lines.
Hyperfine fields are the measure of the internal field in the nucleus of a particular iron atom. A
metallic iron atom has a hyperfine field of 330 kG, which will Zeeman split and span the spectrum
between ± 5.1 mm/s. However, the oxides have a much larger field (anywhere from 490 kG
upwards), which will span the spectrum over a range larger than 5.1 mm/s.
Samples were run at 6 K to avoid potential relaxation effects. Nanoparticles below a critical size
are superparamagnetic at room temperature and can yield a non-Zeeman split spectrum; samples
were run at room temperature (293 K) to determine this characteristic. Samples were run between
6 K and 300 K to find their blocking temperature.

Results
Characterization
Transmission Electron Microscopy
TEM results show that the diameter of nanoparticles for Sample JK001 are 4-7 nm with 20-70 nm
agglomerates (Figure 10). TEM results also revealed excess coating that had not been removed by
sample washing (Figure 10D, 10F). Sample JK001 demonstrates an excellent core and shell
structure (Figures 10A, 10C, 10G, and 10D). However, some particles seemed to have completely
oxidized and no longer retain their iron core as evident in Figures 10E and 10H. Other notable
characteristics include rod shaped figures visible in Figure 10G.
Sample JK002 are 4-12 nm (Figures 11A and 11B) with 60-150 nm agglomerates (Figures 11E
and 11D). Residual coating appears to remain in this sample as well (Figure 11F). Sample JK002
demonstrated a greater size distribution than Sample JK001 (Figure 11C compared to Figure 10E).
As in Sample JK001, some particles seem to have completely oxidized at the time of
characterization (Figures 11A and 11B). TEM was performed on Samples JK001 and JK002 four
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and three days after synthesis respectively, so smaller particles may have oxidized from the shell
inward before characterization.
Sample JK003 are 3-7 nm (Figures 12A and 12B) with 25-40 nm agglomerates (Figure 12C).
Sample JK003 demonstrates excellent size distribution overall. Similarly to JK001, there are rodlike structures present (Figure 12D) and some particles seem to have completely oxidized (Figures
12A and 12D).
Sample JK004 is 4-11 nm (Figures 13A, 13B, and 13C) with 45-150 nm agglomerates (Figures
13B and 13D), and there appears to be lots of residual coating (Figures 13D and 13C). Sample
JK005 is 11-33 nm with agglomerates >330 nm (Figures 14A and 14B). This sample has notable
core and shell structures ranging from 11-18 nm cores and 20-33 nm with a shell (Figures 14A and
14B). Sample JK006 is 13-48 nm (Figure 15A) with agglomerates >340 nm (Figure 15B). Like
JK005, Sample JK006 also has a notable core and shell structure. Sample JK007 is 32-52 nm with
agglomerates >440 nm (Figure 16) and has a thicker coating than previous samples. It is difficult
to discern individual particle sizes in this sample.
Sample JK018 is 8-35 nm (Figure 17C) with agglomerates >230 nm (Figures 17A and 17B). JK018
had several extremely large particles (Figures 17D and 17E). Figures 17A and 17B appear to show
remnants of coating, poor workup and/or coated agglomerates. Sample JK018 demonstrated the
largest size distribution in TEM while Sample JK003 had the smallest visible size distribution. A
summary of these results can be seen in Table 2.
TEM indicates all the nanoparticles are coated and agglomerated. The results infer a larger reaction
distance created by using the separatory funnel produced a smaller iron core; the sodium
borohydride was able to reduce the iron (ii) chloride more with the greater distance allowed. The
Brij 30 appeared to be a superior coating over the polyethylene glycol 600 diacid. The sample
coated in polyethylene glycol 600 diacid (JK007) was ≥50 nm in diameter, and the thickness of its
coating was greater than that of Brij 30 coated samples. The result is a product too large for contrast
agent applications.
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Table 2 TEM size analysis of iron chloride reduction samples
Sample
JK001
JK002
JK003
JK004
JK005
JK006
JK007
JK011
JK012
JK018
JK019

Smallest Diameter
3.8 nm
4 nm
3 nm
4 nm
11 nm
8 nm core, 13 nm total
17 nm core, 32 nm total
n/a
n/a
8 nm
n/a

Largest Diameter
6 nm core, 7 nm total
12 nm
6.5 nm
11 nm
11 nm core, 33 nm total
25 nm core, 48 nm total
32 nm core, 52 nm total
n/a
n/a
35 nm
n/a

Agglomerates
20-70 nm
60-150 nm
25-40 nm
45-150 nm
330 nm, >400 nm
>340 nm
>440 nm
n/a
n/a
>230 nm
n/a
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Dynamic Light Scattering
DLS cumulants results of Sample JK001 indicated a particle size of 1421.7 nm with a
polydispersion index (PDI) of 0.772. Sample JK002 yielded a particle size of 383.2 nm with PDI
of 0.226. Sample JK007 results gave a particle size of 11,368.9 nm with a pdi of 5.035. Sample
JK011 exhibited particle size of 959.1 nm with a pdi of 0.572. Sample JK012 cumulant results
gave a particle diameter of 818.9 nm with a pdi of 0.485.
DLS cumulants results contradicted TEM images and characterized particles as up to 11,000 nm
in size. Polydispersion indexes (PDI) for samples ranged from 0.226 to 5.065. An ideal PDI,
meaning particles are monodispersed, is a value of 0.0. Sample JK007’s PDI was especially off
indicating a very broad size distribution. Sample JK002 was closest to an ideal PDI. Intensity,
number, and volume distribution analysis were performed to discern agglomerate groups and
provide an explanation for the high particle size results. The cumulants results of samples and their
PDI are compared to TEM results in Table 3.
Sample JK001 yielded three distribution peaks. Intensity results show particle sizes of 90.2 nm ±
9.5 nm, 598.6 nm ± 109.3 nm, and 20,908.7 nm ± 4,657.2 nm. Number distribution values for
JK001 are 84.8 nm ± 1.0 nm, 497.7 nm ± 82.1 nm, and 16,198.4 ±3,011.1 nm. Volume distribution
values for JK001 are 87.3 nm ± 9.0 nm, 542.6 nm ± 97.9 nm, and 18,151.9 nm ± 3, 9010.8 nm...
Sample JK001 distribution results are presented in Figure 18.
Sample JK002 yielded one distribution peak. Intensity results for JK002 are 520.7 nm ± 306.5 nm.
Number distribution values for JK002 are 160.6 nm ± 45.9 nm. Volume distribution values for
JK002 are 227.4 nm ± 113.3 nm. Sample JK002 distribution results are presented in Figure 19.
Sample JK007 yielded two distribution peaks. Intensity results for JK007 are 253.9 nm ± 24.0 nm
and 34,006.6 nm ± 6,609.9 nm. Number distribution values for JK007 are 241.6 nm ± 20.9 nm and
27,720.3 nm ± 4,761.9 nm. Volume distribution values for JK007 are 247.3 nm ± 22.8 nm and
30,466.9 nm ± 5,804.3 nm. Sample JK007 distribution results are presented in Figure 20.
Sample JK011 yielded two distribution peaks. Intensity results for JK011 are 462.4 nm ± 53.5 nm
and 19,244.6 nm ± 3,153.0 nm. Number distribution values for JK011 are 444.2 nm ± 51.3 nm and
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Table 3 DLS cumulant results compared to TEM results (particle size, agglomerate size)
Sample
JK001
JK002
JK003
JK004
JK005
JK006
JK007
JK011
JK012
JK018
JK019

DLS Diameter
1421.7 nm
383.2 nm
n/a
n/a
n/a
n/a
11368.9 nm
959.1 nm
818.9 nm
n/a
n/a

PDI
0.772
0.226
n/a
n/a
n/a
n/a
5.035
0.572
0.485
n/a
n/a

TEM Diameter
3-7 nm, 20-70 nm
4-12 nm, 60-120 nm
3-7 nm, 25-40 nm
4-11 nm, 45-145 nm
11-33 nm, >330 nm
13-48 nm, >340 nm
32-52 nm, >440 nm
n/a
n/a
8-35 nm, >230 nm
n/a
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17,733.3 nm ± 2,942.9 nm. Volume distribution values for JK011 are 427.7 nm ± 47.5 nm and
16,439.8 nm ± 2,558.9 nm. Sample JK011 distribution results are presented in Figure 21.
Sample JK012 yielded two distribution peaks. Intensity results for JK012 are 480.2 nm ± 54.5 nm
and 16,694.0 nm ± 2,096.0 nm. Number distribution values for JK012 are 462.1 nm ± 52.4 nm and
15,892.9 nm ± 2,055.9 nm. Volume distribution values for JK012 are 445.5 nm ± 48.6 nm and
15,135.0 nm ± 1,919.0 nm. Sample JK012 distribution results are presented in Figure 22. A
summary of DLS results for each distribution can be seen in Tables 4, 5, and 6.
Cytotoxicity
Cytotoxicity studies of Sample JK003 were carried out and analyzed at Vanderbilt University. The
two cell plates used were imaged using an in vivo optical imaging system. It measured the
luminescence of the wells in radiance (photons). The higher radiance in the wells represents more
surviving cells. As seen in Figure 23, the brightly colored cells (red, yellow, and green) had
excellent survival rates and the dark wells (dark blue and black) represent cell death. The process
was repeated for the 24 hour and 48 hour time points for both plates (Figure 24). A summary of
these results can be seen in Figure 25 with the luminescence of untreated control samples
normalized to 100.
Cell proliferation and viability was comparable to untreated and ethanol controls for the 1:640,000
iron nanoparticle dilution and all incubation durations, suggesting the lack of acute or chronic
toxicity at this dose. Toxicity was broadly proportional to iron nanoparticle dose with significant
cell death at elevated concentrations of iron nanoparticles, which was especially evident for
dilutions less than approximately 1:10,000. Toxicity was not consistently different as a function
of incubation duration, suggesting a rapid suppression of cell metabolism at high iron nanoparticle
doses.
With a dilution rate of 1:640,000 by volume, the cells had a good survival rate compared to the
ethanol control. At 24 hours, the average radiance of cells diluted to 1:640,000 was 90; by
comparison, the ethanol control had an average radiance of 68 at the same time point. The
1:400,000 dilution rate represented a median amount of cell survival. These results indicate that
the sample is not toxic to cells at a diluted rate and can intentionally kill cells (if desired) at higher
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concentrations.
Toxicity of concentrated iron nanoparticles could also serve as a treatment for inoperable brain
tumors. In this treatment, uncoated iron nanoparticles would be directly injected into the tumor.
Toxicity of the uncoated nanoparticles would cause cell death to the tumor and not to the
surrounding healthy cells (Yu).
Mössbauer Spectroscopy
In a paramagnetic material, spins are oriented when an external magnetic field is applied. This is
reversible, i.e. the spins are disoriented when the magnetic field is removed. Magnetically ordered
materials (ferromagnets, ferrimagnets) are composed of domains consisting of interacting spins,
which are oriented when an external magnetic field is applied. But when the magnetic field is
removed the domains are not completely disoriented (Hysteresis). MNPs that are the size of a
single magnetic domain respond to an external magnetic field but do not become permanently
magnetized, i.e. they are superparamagnetic (Huang). The domain magnetic moments fluctuate
with a relaxation time. Magnetite, or Fe3O4, has a domain size of 15-80 nm (Huang).
The detection of Fe3+ in Mössbauer would represent oxidation. Any particles smaller than 10 nm
could be superparamagnetic and would therefore present as a broad line. This could split into 6
lines at low temperatures when the relaxation has slowed down.
Sample JK002 dried in air and run at room temperature was depicted as a broad singlet (Figure
27), and confirms the particles are small but unlikely less than 5 nm in diameter as the peak would
appear more narrow; this was confirmed by TEM. Sample JK002 at 6 K initially presented as iron
metal (Figure 26); however, two months after synthesis, the samples presented as an oxide,
specifically γ-Fe2O3 in the spectra seen in Figure 28.
The spectra of Sample JK003, run at 9 K in the cryostat (Figure 29) closely matches the iron
calibration spectra (±5.2mm/sec or 330 kG) but with broader lines. Sample JK003 was run again
three and a half years after synthesis at 6 K (Figure 30); this revealed the sample had become 81%
oxide. The sample was stored in a sealed vial and kept in air over this period. The sample was run
again four years after synthesis at 6 K, 293 K, and 293 K with a 10 kG field. The results can be
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seen in Figures 31, 32, and 33. Four years post-synthesis the sample had maintained 15% metallic
iron. This is an increase in oxidation of 4% over six months. 85% of the sample had mostly
oxidized to γ-Fe2O3 resembling Sample JK002. We believe the smaller iron metal nanoparticles
fully oxidized to γ-Fe2O3 and the larger iron metal nanoparticles maintained a metallic core with a
γ-Fe2O3 shell. The preservation of metallic iron could be attributed to Sample JK003’s longer
reaction time and/or the efficiency of the coating. The 10 kG spectra (Figure 33) at room
temperature confirms Sample JK003 contains nanoparticles due to its large susceptibility.
Sample JK004 ran at 6 K revealed the sample was completely oxidized (Figure 34). Sample JK007
was determined to be a mix of iron metal (59%) and iron oxide (41%) according to Mössbauer
spectroscopy (Figure 35).
Sample JK011 at room temperature (Figure 37) closely resembles the Mössbauer spectrum of
FeCl2 reactant used in the synthesis (Figure 43). This indicates much of the sample, if any, did not
reduce to form iron nanoparticles. Sample JK012 revealed quadrupole splitting similar to its iron
chloride reactant but not matching it (Figures 39-42). Samples JK018 and JK019 both contained a
mix of iron metal and iron oxides (Figures 44-51). A summary of these results can be seen in Table
4.

Discussion
The characterization results show that small nanoparticles (3-20 nm) were successfully
synthesized, most likely due to a longer reaction length. Synthesis utilizing the separatory funnel
resulted in smaller particles than those synthesized without the funnel, which could be due to a
longer reaction length or faster synthesis rate. The polyethylene glycol 600 diacid coating led to
more cross linkage and larger particles. Samples synthesized without a syringe pump resulted in
high size distributions.
DLS cumulants results were artificially high compared to TEM characterization. The conflicting
DLS results suggests the samples were not correctly prepared. If the samples were not completely
suspended, the movement of the particles settling would yield artificial results since the software
uses Brownian motion in its algorithm to determine particle size. Another contributing factor to
these results could be the failure to adequately sonicate the sample. As-made samples were
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Table 4 Mössbauer results of iron chloride reduction samples
Sample
JK002
JK002
JK002
JK003
JK003
JK003
JK003
JK003
JK004
JK007
JK011
JK011
JK011
JK012
JK012
JK012
JK012
FeCl2
JK018
JK018
JK018
JK019
JK019
JK019
JK019
JK019
JK019

Temp
6K
6K
293K
6K
5.4K
5K
293K
293K
6K
6K
293K
293K
6K
293K
293K
180K
6K
293K
6K
293K
300K
6K
6K
6K
270K
293K
293K

Field

10 kG

10 kG
10 kG

0.073T parallel
0.073T perpendicular
10 kG perpendicular

Site 1
100.00%
100.00%
100.00%
100.00%
81.45%
85.17%
57.94%
12.87%
100.00%
40.77%
100.00%
100.00%
100.00%
100.00%
100.00%
41.23%
27.71%
73.62%
99.01%
47.57%
100.00%
22.38%
18.88%
17.85%
7.59%
6.07%
3.19%

Site 1 Hyperfine
341.30
463.48
000.00
511.20
512.45
512.34
0.0 (0.78 quad)
323.54
518.52
475.96
0.0 (0.75 quad)
0 (0.74 quad)
0.0 (2.98 quad)
0.0 (2.23 quad)
0.0 (2.21 quad)
0.0 (2.64 quad)
0.0 (3.25 quad)
0.0 (0.78 quad)
0.0 (5.64 quad)
344.39
407.30 (0.64 quad)
347.72
246.09
343.99
330.0
330.0
330.0

Site 1
I/S
0.12
0.47
0.33
0.46
0.46
0.45
0.33
0.00
0.46
0.46
0.36
0.37
1.35
1.25
1.29
1.33
1.34
1.08
0.00
0.17
0.20
0.12
0.11
0.11
0.00
0.00
0.00

Site 2

Site 2 Hyperfine

Site 2
I/S

18.55%
14.83%
42.06%
8.64%

342.39
341.48
330.00
0.0 (0.86 quad)

0.11
0.12
0.02
0.32

59.23%

338.03

0.15

58.77%
72.29%
26.38%
0.09%
52.43%

520.0 (5.55 quad)
520.0 (5.34 quad)
0.0 (2.00 quad)
0.0 (2.79 quad)
274.17

2.91
2.93
1.15
-1.67
0.22

77.62%
81.12%
82.15%
92.41%
93.93%
96.80%

293.93
299.96
294.44
251.83
242.63
405.78 (0.71 quad)

0.19
0.23
0.23
0.07
0.00
0.20
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concentrated after synthesis and washed from their reaction solvents for storage. When resuspending these particles, it is possible agglomerates were never fully broken up. A longer
sonication time or alternate sonication method may alleviate this issue.
Agglomeration can also be attributed to the nature of the synthesis – the particles form as
agglomerates during the reaction due to the synthesis rate in both uncontrolled and controlled by
a syringe pump. The coatings utilized to ensure biocompatibility and prevent oxidation bind the
agglomerates together as evident in TEM. When the agglomerates are broken up via sonication,
the coating may be disrupted and the particles could be left vulnerable to oxidation.
Cytotoxicity results show that cells are able to survive when introduced to the iron nanoparticles
at low concentrations. At higher, intense concentrations, the cells did not survive; this is
advantageous if the nanoparticles are intended for direct injection into diseased cells.
Mössbauer Spectroscopy shows that Sample JK002, synthesized with a short reaction length,
contains superparamagnetic γ-Fe2O3 and metallic iron was produced in Sample JK003 with a
longer reaction length. The most encouraging results are the discovery of metallic iron
nanoparticles and the presence of metallic iron after four years of storage in air. Mössbauer
Spectroscopy also shows that samples JK011 was not reduced to form iron nanoparticles. This
might be attributed to initial inconsistency with the syringe pump used. Sample JK018 and JK019
appeared to be a mix of iron and oxides as synthesized. This could be to the lack of inert reaction
environment.
Future Work
Future work should include the exploration of different reaction rates and coatings, sonication
before coating, and/or a different source of iron. Solving the agglomeration issue is necessary for
biomedical applications as the agglomerated clumps of iron act as one large particle; this affects
the magnetic properties of the product and clearance from the body. Both the magnetic properties
and size distribution of the nanoparticles are important for use as MRI contrast agents; the
nanoparticles should be small (less than 10 nm) and monodispersed. We will also study the causes
of oxidation and reasons for different oxidation rates over time between the samples (months
versus years). An entirely different synthesis procedure may be required to prevent any
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agglomeration and oxidation such as thermal decompositions
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Chapter II Appendix

Figure 1 Synthesis of JK001, JK003, JK006, and JK007
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Figure 2 Synthesis of JK002, JK004, JK005

Figure 3 Magnetic separation of JK002
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Figure 4 Synthesis of JK009
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Figure 5 Synthesis of JK018-JK019
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Figure 6 JK001 prepared for TEM characterization
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Figure 7 DLS sample of A) JK001 and B) JK007
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Figure 8 Cell concentration and viability assessed using a hematocytometer

Figure 9 Mössbauer apparatus setup
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Figure 10 Preparation of Mössbauer sample

38

A
A

B
A

C
A

D
A

Figure 11 TEM of JK001

39

E
A

F
A

G
A

H
A

Figure 11 continued
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Figure 12 TEM of JK002
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Figure 13 TEM of JK003
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Figure 14 TEM of JK004
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Figure 15 TEM of JK005
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Figure 16 TEM of JK006
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Figure 17 TEM of JK007
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Figure 18 TEM of JK018
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Figure 18 continued
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Figure 19 DLS results of JK001
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Figure 20 DLS of JK002
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Figure 21 DLS results of JK007
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Figure 22 DLS results of JK011
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Figure 23 DLS results of JK012
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Figure 24 Plate one at 17, 24, and 48 hour timepoints
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Figure 25 Plate one and two cytotoxicity results
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Figure 25 continued
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Figure 26 Summary of cytotoxicity results

Figure 27 Mössbauer Spectrum of JK002 at 6 K
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Figure 28 Mössbauer Spectrum of JK002 at 293 K

Figure 29 Mössbauer Spectrum of JK002 at 6 K Two Months Post Synthesis
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Figure 30 Mössbauer Spectrum of Sample JK003 at 6 K

Figure 31 Mössbauer Spectrum of JK003 at 6 K Four Years and 4 Months Post Synthesis
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Figure 32 Mössbauer Spectrum of JK003 at 6 K Four Years and 9 Months Post Synthesis

Figure 33 Mössbauer Spectrum of JK003 at 293 K Four Years and 9 Months Post
Synthesis
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Figure 34 Mössbauer Spectrum of JK003 at 293 K with a 10 kG Field Four Years and 9
Months Post Synthesis

Figure 35 Mössbauer Spectrum of JK004 at 6 K
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Figure 36 Mössbauer Spectrum of JK007 at 6K

Figure 37 Mössbauer Spectrum of JK011 at 6K
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Figure 38 Mössbauer Spectrum of JK011 at 293 K

Figure 39 Mössbauer Spectrum of JK011 at 293 K with a 10 kG Field
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Figure 40 Mössbauer Spectrum of JK012 at 6 K

Figure 41 Mössbauer Spectrum of JK012 at 180 K
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Figure 42 Mössbauer Spectrum of JK012 at 293 K

Figure 43 Mössbauer Spectrum of JK012 at 293 K with a 10 kG Field
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Figure 44 Mössbauer Spectrum of Anhydrous FeCl2

Figure 45 Mössbauer Spectrum of JK018 at 6 K
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Figure 46 Mössbauer Spectrum of JK018 at 293 K

Figure 47 Mössbauer Spectrum of JK019 at 6 K
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Figure 48 Mössbauer Spectrum of JK019 at 6 K with a 0.073 T Parallel Field

Figure 49 Mössbauer Spectrum of JK019 at 6 K with a 0.073 T Perpendicular Field
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Figure 50 Mössbauer Spectrum of JK019 at 270 K

Figure 51 Mössbauer Spectrum of JK019 at 293 K
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Figure 52 Mössbauer Spectrum of JK019 at 293 K with a 10 kG Field
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CHAPTER III
THERMAL DECOMPOSITION OF IRON PENTACARBONYL
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Introduction
The goal of the work presented in this chapter was to synthesize spherical iron nanoparticles less
than 10 nm in diameter by thermal decomposition. The ability of various biocompatible coatings
to protect the metallic iron nanoparticles from oxidation was investigated. Coatings studied
included Brij, polyethylene glycol and iron oxide. Transmission electron microscopy and
Mössbauer spectroscopy were utilized to characterize the coated and uncoated iron nanoparticles’
size and oxidation state to evaluate the effectiveness of the coatings and the procedures in which
the coatings were applied. A ferrite shell was found to provide the best stabilization; however, its
longer synthesis time increased particle size distribution. Polymer coatings provided
biocompatibility but did not prevent oxidation.

Methods
Iron Oleate Synthesis
Iron oleate was synthesized for the iron nanoparticle ferrite shell using a modified synthesis of
nanocrystals reported in Park 2004 (Park). Sodium hydroxide, ethanol, deionized water, and oleic
acid were mixed together in a round bottom flask for 1 hour. Hexane and iron (III) chloride were
added to the flask, and the mixture was stirred for 15 minutes. The resulting mixture can be seen
in Figure 53. The iron oleate/salt mixture was transferred to a separatory funnel where the sodium
chloride was washed from the iron oleate. DI water was added to the separatory funnel, mixed by
swirling and the sodium chloride was funneled out (Figure 54) until the sodium chloride was
completely removed (Figure 55). The hexane was distilled off leaving behind the iron oleate
complex seen in Figure 56.
Iron Nanoparticle Synthesis
The iron nanoparticle samples were synthesized by thermal decomposition in a nitrogen
environment. Similar to Peng 2006, octadecene, oleylamine, and hexane were used in the
synthesis. Peng’s synthesis method was modified to produce zero-valent iron nanoparticles as
opposed to iron oxide nanoparticles reported in the paper (Peng). Octadecene was dried with NaK
then filtered through a 0.45 µm filter using a 30 mL disposable syringe. Dried, filtered octadecene
and degassed hexane were deposited into a three-neck round bottom flask. Continuous nitrogen
72

flowed through a bent stopcock adapter. The remaining flask necks were fitted with a condenser
tube and sealed with a septum (Figure 57). The octadecene and oleylamine were heated at 120ºC
and stirred at 200 rpm for 30 minutes. The temperature was raised to 250ºC or 230ºC and Fe(CO)5
was injected into the flask through a septum. A violent burst of black/green/yellow/grey smoke
blew from the top of the condenser- this can be seen in Figure 58. The reaction was left to stir for
20 or 40 minutes at 250ºC or 230ºC and then allowed to cool to room temperature. A summary of
synthesis conditions can be found in Table 5.
Iron Oleate Shell
Annealing the ferrite shell was carried out in a separate reaction after the synthesis. This was done
to ensure the particle size would remain less than 10 nm (Bronstein). Once cool 0.1-0.4 mL of iron
oleate complex was injected into the reaction flask of the samples. The mixture was stirred at room
temperature for 30 minutes and then placed in a preheated oil bath. The temperature was raised to
250ºC/230ºC and held there for one hour to anneal the iron oleate to the nanoparticle core. Once
cool, the flask was flushed with nitrogen and sealed until sample washing and further coating.
Sample Washing and Coating
Sample Washing

Samples were poured from the reaction flask into glass jars; the samples often left metallic flake
residue on the flask walls (Figure 59). Ethanol (Deacon Labs) was added to each jar to precipitate
the nanoparticles from their solution. The jars were shaken to mix the ethanol and particles. The
jar was placed on a neodymium magnet to separate the nanoparticles from the reaction solvents
(Figure 60). An oily liquid was pulled off the top with a pipet. This process was repeated until the
reaction solvents had been removed. Once washed, degassed hexane was added to re-suspend the
particles.
Sample Coating

Table 5 summarizes the samples and their corresponding coating. Samples JK026 and JK027 were
coated with a Brij solution. 5 mL Brij 30 and 25 mL of ethanol were added to a round bottom flask
and mixed well. The washed sample, JK026, was added dropwise into the Brij solution. The
mixture was stirred in the flask for 30 minutes, and then sonicated for 1 hour. Sample JK027 was
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Table 5 Thermal decomposition synthesis conditions
Sample Synthesis Type
JK020
JK021
JK022
JK023
JK024
JK025
JK026
JK027
JK028
JK029
JK030
JK031
JK032
JK033
JK034

Thermal decomposition 1.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 1.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 1.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 1.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 1.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.8 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.8 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 7.2 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 7.2 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY

Coating

Reaction
Temp.

Reaction
Time

Anneal
Temp.

Anneal
Time

Injection
Time

Smoke
Color

none

250°C

20 min.

n/a

n/a

-

-

0.4 mL iron oleate

250°C

20 min.

250°C

1 hour

-

-

0.4 mL iron oleate

250°C

20 min.

250°C

1 hour

-

-

none

250°C

40 min.

n/a

n/a

-

-

none

250°C

20 min.

n/a

n/a

-

-

0.4 mL iron oleate

250°C

20 min.

250°C

1 hour

-

-

0.4 mL iron oleate
+ Brij 30

250°C

20 min.

250°C

1 hour

-

-

Brij 30

250°C

20 min.

n/a

n/a

-

-

0.1 mL iron oleate
+ PEG 300

250°C

20 min.

250°C

1 hour

-

-

0.1 mL iron oleate

250°C

20 min.

250°C

1 hour

-

-

none

250°C

20 min.

n/a

n/a

-

-

PEG 300

250°C

20 min.

n/a

n/a

-

-

0.6 mL iron oleate

250°C

10 min.

250°C

1 hour

15 min

grey

0.3 mL iron oleate

250°C

10 min.

250°C

1 hour

1.5 min

black/yellow

0.1 mL iron oleate

250°C

20 min.

250°C

1 hour

0.5 min

white/grey
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Table 5 continued
Sample Synthesis Type
JK034
JK035
JK036
JK038
JK039
JK040
JK041
JK042
JK043

Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.4 mL
Fe(CO)5 in ODE/OY
Thermal decomposition 2.3 mL
Fe(CO)5 in ODE/OY

Coating

Reaction
Temp.

Reaction
Time

Anneal
Temp.

Anneal
Time

Injection
Time

Smoke
Color

0.1 mL iron oleate

250°C

20 min.

250°C

1 hour

0.5 min

white/grey

0.1 mL iron oleate

250°C

20 min.

230°C

1 hour

0.5 min

black/yellow

0.1 mL iron oleate

230°C

20 min.

230°C

1 hour

0.8 min

white

0.1 mL iron oleate

230°C

20 min.

230°C

1 hour

2 min

yellow

0.1 mL iron oleate

230°C

20 min.

230°C

1 hour

1.5 min

grey

0.1 mL iron oleate

230°C

20 min.

230°C

1 hour

2 min

yellow

0.1 mL iron oleate

230°C

20 min.

230°C

30 min

-

-

0.1 mL iron oleate

230°C

20 min.

230°C

1 hour

15 sec.

black/yellow

0.1 mL iron oleate

230°C

20 min.

230°C

1 hour

2 min

-
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coated with a ferrite shell prior to washing. 60 mL of Brij 30 suspended in ethanol was added to a
round bottom flask. The ferrite-coated sample JK027, was poured into the flask containing the Brij
solution. The solution was stirred at 200 rpm for 1 hour. The sample mixture was poured into
sample jars and sonicated for 1 hour.
Samples JK028 and JK031 were coated with a PEG 300. Sample JK028 had a ferrite shell annealed
before washing while Sample JK030 had no ferrite shell added. Sample JK028 was coated by
injecting 0.3 mL of PEG 300 and stirred for 30 minutes at 1200 rpm under nitrogen flow. Sample
JK031 had 0.25 mL PEG 300 added after washing and was stirred at 300 rpm for 20 minutes. Both
samples were coated while in a nitrogen gas flow.
Transmission Electron Microscopy (TEM)
Transmission electron microscopy (TEM) was performed using a Zeiss Libra 120 at Oak Ridge
National Laboratory (ORNL). Samples were prepared by diluting the nanoparticles with hexane
until the solution was barely tinted. A copper TEM grid was dipped into the solution and dried in
air. Samples JK020, JK021, JK022, JK023, JK026, JK027, JK028, JK029, JK030, JK038, JK039,
JK040, JK041, JK042 and JK043 were characterized using this technique.
Dynamic Light Scattering
Dynamic Light Scattering (DLS) analysis was performed at the University of Tennessee Space
Institute, Tullahoma, TN using a Particulate Systems NanoPlus Zeta/Nano Particle Analyzer.
Samples were prepared by diluting the nanoparticles with ethanol until the solution was barely
tinted. The diluted solution was pipetted into a quartz cuvette. Analysis was performed using the
NanoPlus software program. Samples JK017, JK020, JK021, JK022, JK023, JK024, JK025,
JK026, JK027, JK028, JK029, JK030, and JK031 were characterized using this technique.
Mössbauer Spectroscopy
Mössbauer Spectroscopy and analysis was performed at the University of Tennessee Space
Institute, Tullahoma, TN. A 57Co source was used for the calibration and sample measurements.
The iron nanoparticle samples were dried in an inert atmosphere then frozen prior to
characterization. Samples JK020, JK021, JK023, JK025, JK026, JK027, JK028, JK029, JK030,
JK031, JK032, JK033, JK034, and JK036 were characterized using this technique
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Results
Transmission Electron Microscopy (TEM)
TEM was performed on samples JK020, JK021, JK022, JK023, JK026, JK027, JK028, JK029,
JK030, JK038, JK039, JK040, JK041, JK042 and JK043. A summary of their results can be seen
in Table 6. Samples JK021 and JK022 still had reaction solvent present and was therefore too oily
to image particles with TEM.
JK020 was imaged several days after synthesis and had no protective shell or additional coating.
TEM showed monodispersed particles with an apparent metallic core surrounded by an oxide shell.
The particles were 10 nm in diameter and can be seen in Figure 61.
Sample JK023 had aggregates of 130 nm present (Figure 62). Individual particles had a discernable
core-shell structure (Figure 62). The smallest core appeared to be 2 nm (Figure 62) and the largest
total diameter (core and shell) was measured at 13 nm (Figure 62).
Sample JK026, see Figure 63, exemplified particle sizes of 2 to 13 nm with cores of 2 to 6 nm.
JK027, which was only coated with Brij 30, had slightly smaller measurements than JK026, which
had a ferrite shell and Brij 30 coating. JK027 had cores measured at 2-5 nm and total diameters of
3-10 nm. Despite the coating, JK027 still appears to have particles that oxidized completely
(Figure 64). The small particle size and possible exposure to air during sample washing and coating
are both contributing factors to this result. Samples JK026 and JK027 were both agglomerated
with measured agglomerates of 72 and 90 nm, respectively.
JK028, seen in Figure 65, had core structures which measured 3-10 nm and total particle diameters
of 4-14 nm. While agglomerates were imaged for JK028 at 280 nm, no agglomerates were recorded
in JK029. It is unlikely there are no agglomerates, but agglomerates were just not imaged (Figure
66). Sample JK029 exhibited metallic cores ranging from 1 to 9 nm in diameter and total diameters
of 4 to 12 nm. This can be seen in Figure 66. Upon visual inspection, samples JK029 and JK026
had a greater size distribution than samples JK020 and JK030. During annealing, the nanoparticles
were subjected to a longer duration of high temperatures causing the particles to grow. This
explains the greater distribution in size.
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Sample JK030 was imaged four hours after synthesis and had no protective shell or coating.
Sample JK030 exhibited almost complete oxidation of the metallic iron core within 4 hours of
synthesis. The smallest core size was 3 nm with the largest core of 11 nm. The total particle size
varied from 4-13 nm (Figure 67). Agglomerates were measured at greater than 190 nm. The
remaining core shells that had not yet fully oxidized were 5 nm in diameter and can be seen in
Figure 67. This emphasizes the importance of a protective coating; both the ferrite shell and PEG
300 coatings protect the iron core enough to mostly prevent complete oxidation.
Samples JK020 and JK030 had similar syntheses but showed very different stages of oxidation. It
could be that JK020 formed its own protective shell by oxidizing inward. JK030 was similar to
JK029 in that they have approximately the same diameters and the size distributions were not as
large as coated samples. This proved the annealing process grows the nanoparticles.
The particle size of JK038 is seen as 4-10 nm cores, 7-15 nm total diameters with agglomerates
greater than 100 nm (Figure 68). JK039 had cores measured at 3-9 nm and total diameters at 7-14
nm with agglomerates of 18-250 nm (Figure 69). JK041 was measured with cores of 4-8 nm, total
particles sizes of 7-13 nm and 26-87 nm agglomerates (Figure 70). JK042 total particle sizes varied
from 6-11 nm with cores of 3-6 nm. The sample had agglomerates up to 1545 nm (Figure 71).
Samples JK040 and JK043 appeared to have not been washed thoroughly (Figure 72); however it
can be noted there are large agglomerates present in both samples (Figure 73). A summary of these
TEM results can be found in Table 6.
JK038, JK039, JK041, and JK042 all appeared similar under TEM. This is expected as the sample
synthesis conditions are largely the same. Noted differences in synthesis conditions are minimal:
JK041’s annealing time of 30 minutes as opposed to one hour and JK042’s quick injection time of
15 seconds compared to 1.5-2 minutes. This indicates the designed reaction can be successfully
duplicated. If iron oxide nanoparticles of less than 10 nm in diameter are desired, this would be a
suitable reaction to utilize.
Another factor investigated in these samples are the correlation to iron pentacarbonyl injection
time. JK042 had the quickest injection time at 15 seconds while JK038 had the longest injection
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Table 6 TEM results of thermal decomposition samples

Sample
JK020
JK021
JK022
JK023
JK024
JK025
JK026
JK027
JK028
JK029
JK030
JK031
JK032
JK033
JK034
JK035
JK036
JK038
JK039
JK040
JK041
JK042
JK043

Core Diameter

Total Diameter

Agglomerates

2-5 nm
n/a
n/a
2 to 7 nm
n/a
n/a
2 to 6 nm
2-5 nm
3-10 nm
1-9 nm
3-11 nm
n/a
n/a
n/a
n/a
n/a
n/a
4-10 nm
3-9 nm
6-13 nm
4-8 nm
3-6 nm
n/a

6-11 nm
n/a
n/a
7 to 13 nm
n/a
n/a
2 to 13 nm
3-10 nm
4-14 nm
4-12 nm
4-13 nm
n/a
n/a
n/a
n/a
n/a
n/a
7-15 nm
7-14 nm
9-16 nm
7-13 nm
6-11 nm
n/a

n/a
n/a
n/a
130 nm
n/a
n/a
72 nm
90 nm
280 nm
n/a
>190 nm
n/a
n/a
n/a
n/a
n/a
n/a
>100 nm
18 - 250 nm
735 nm
26-87 nm
1545 nm
>450 nm
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time studied at 2 minutes. There is only a slight difference in size distribution (within nm) in TEM
results. This rejects the hypothesis that particles beginning to form initially upon injection are
notably larger than those beginning to form at the end of the injection.
Dynamic Light Scattering (DLS)
Dynamic Light Scattering (DLS) yields cumulants results, polydispersion index and distribution
results for number, volume, and intensity. Cumulants results are the average particle size
determined by analysis software. Polydispersion index (pdi) yields a number correlated to the
particle size distribution. A perfectly monodispersed sample would yield a 0.0 pdi. All cumulants
results evaluated for these samples fall between the smallest and largest dispersion measurements.
This indicates groups of particle sizes that are smaller and larger than the average measurement.
The cumulants results for JK020 are 6,580.1 nm with a pdi of 1.227. JK020 had two distribution
peaks. The intensity distribution of JK020 was 61.4 ± 2.3 nm and 31,088.2 ± 5,193.9 nm. Volume
distribution was 61.1 ± 2.2 nm and 28,641.4 ± 4,719.2 nm. Number distribution was 60.9 ± 2.0
nm and 26,623.2 ± 4,052.5 nm. The distribution results are graphed in Figure 74.
The cumulants results for JK021 are 27,644.1 nm with a pdi of 3.133. JK021 had three distribution
peaks. The intensity distribution of JK021 was 177.8 ± 8.3 nm, 3,036.9 ± 437.0 nm, and 130,290.0
± 27,252.8 nm. Volume distribution was 176.6 ± 8.2 nm, 2,859.9 ± 401.3 nm, and 114,878.0 ±
23,347.6 nm. Number distribution was 175.6 ± 7.9 nm, 2,713.0 ± 349.4, and 103,528.0 ± 18,492.4
nm. The distribution results are graphed in Figure 75.
The cumulants results for JK022 are 6,712.9 nm with a pdi of 1.118. JK022 had two distribution
peaks. The intensity distribution of JK022 was 72.1 ± 2.9 nm and 24,075.7 ± 4,071.7 nm. Volume
distribution was 71.8 ± 2.7 nm and 22,159.6 ± 3,659.4 nm. Number distribution was 71.5 ± 2.6
nm and 20,616.9 ± 3,103.1 nm. The distribution results are graphed in Figure 76.
The cumulants results for JK023 are 6,580.1 nm with a pdi of 1.227. JK020 had four distribution
peaks. The intensity distribution of JK023 was 52.2 ± 2.1 nm 244.5 ± 20.9 nm, 787.2 ± 146.8, and
40,102.6 ± 7,662.3 nm. Volume distribution was 51.9 ± 2.1 nm, 239.2 ± 20.5 nm, 710.3 ± 131.1

80

nm, and 36,073.5 ± 6,738.4 nm. Number distribution was 51.7 ± 2.1 nm, 234.2 ± 19.3 nm, 650.1
± 107.9 nm, and 32,944.0 ± 5,542.4 nm. The distribution results are graphed in Figure 77.
The cumulants results for JK024 are 4,576.7 nm with a pdi of 0.909. JK024 had two distribution
peaks. The intensity distribution of JK024 was 51.5 ± 2.0 nm and 34,813.0 ± 6,571.4 nm. Volume
distribution was 51.3 ± 1.9 nm and 31,412.2 ± 5,774.4 nm. Number distribution was 51.0 ± 1.8
nm and 28,768.3 ± 4,764.8 nm. The distribution results are graphed in Figure 78.
The cumulants results for JK025 are 1,446.7 nm with a pdi of 0.335. JK025 had two distribution
peaks. The intensity distribution of JK025 was 20.6 ± 0.8 nm and 26,597.1 ± 2,282.1 nm. Volume
distribution was 20.5 ± 0.7 nm and 26,002.7 ± 2,269.1 nm. Number distribution was 20.5 ± 0.7
nm and 25,424.6 ± 2,191.2 nm. The distribution results are graphed in Figure 79.
The cumulants results for JK026 are 9,463.3 nm with a pdi of 1.298. JK026 had three distribution
peaks. The intensity distribution of JK026 was 92.3 ± 3.6 nm, 1,136.8 ± 0.2 nm, and 21,375.7 ±
3,805.6 nm. Volume distribution was 91.9 ± 3.4 nm, 1.136 ± 0.3 nm and 19,484.3 ± 3,406.7 nm.
Number distribution was 91.5 ± 3.1 nm, 1,136.8 ± 0.2 nm, and 17,981.7 ± 2,848.1 nm. The
distribution results are graphed in Figure 80.
The cumulants results for JK027 are 1,230.9 nm with a pdi of 0.289. JK027 had three distribution
peaks. The intensity distribution of JK027 was 23.6 ± 2.5 nm, 124.1 ± 8.9 nm, and 19,992.4 ±
2,175.9 nm. Volume distribution was 22.7 ± 2.3 nm, 122.1 ± 8.9nm, and 19,272.6 ± 2,147.8 nm.
Number distribution was 22.1 ± 2.1 nm, 120.3 ± 8.5 nm, and 18,583.0 ± 2,036.6 nm. The
distribution results are graphed in Figure 81.
The cumulants results for JK028 are 5, 080.1 nm with a pdi of 0.948. JK028 had two distribution
peaks. The intensity distribution of JK028 was 51.6 ± 2.1 nm and 24,277.0 ± 4,095.6 nm. Volume
distribution was 51.3 ± 2.0 nm and 22,320.2 ± 3,726.9 nm. Number distribution was 51.1 ± 1.9
nm and 20,709.6 ± 3,188.9 nm. The distribution results are graphed in Figure 82.
The cumulants results for JK029 are 5,218.2 nm with a pdi of 0.962. JK029 had two distribution
peaks. The intensity distribution of JK029 was 51.3 ± 2.0 nm and 22,813.8 ± 3,613.5 nm. Volume
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distribution was 51.1 ± 1.9 nm and 21,200.6 ± 3,299.7 nm. Number distribution was 50.9 ± 1.8
nm and 19,855.0 ± 2,866.7 nm. The distribution results are graphed in Figure 83.
The cumulants results for JK030 are 5,295.8 nm with a pdi of 0.959. JK030 had two distribution
peaks. The intensity distribution of JK030 was 61.8 ± 2.4 nm and 22,458.6 ± 3,633.5 nm. Volume
distribution was 61.5 ± 2.3 nm and 20,786.4 ± 34331.8 nm. Number distribution was 61.3 ± 2.2
nm and 19,385.9 ± 2,888.8 nm. The distribution results are graphed in Figure 84.
The cumulants results for JK031 are 1,971.6 nm with a pdi of 0.429. JK031 had three distribution
peaks. The intensity distribution of JK031 was 30.8 ± 2.3 nm, 440.0 ± 53.0 nm, and 35,235.9 ±
5,292.0 nm. Volume distribution was 30.7 ± 1.0 nm, 421.7 ± 49.9 nm, and 32,874.4 ± 5,036.0 nm.
Number distribution was 30.6 ± 1.0 nm, 405.6 ± 45.3 nm, and 30,771.0 ± 4,502.4 nm. The
distribution results are graphed in Figure 85.
All measurements are greater than any diameter recorded in TEM. This is likely due to
agglomerates not broken up by sonication. Sample JK021 had the greatest pdi of 3.133 while
Sample JK027 had the smallest pdi at 0.289. This result indicates JK027 likely has the largest size
distribution while JK020 is closer to monodispersed. A summary of DLS cumulants results
compared to TEM measurements can be found in Table 7.
Mössbauer Spectroscopy
Mössbauer spectroscopy is a useful technique that allows for the determination of different atomic
valencies in materials. For this study, it is important to distinguish between metallic iron atoms,
which have a 0 mm/s isomer shift, from the Fe3+ and Fe2+ iron oxides which have isomer shifts of
0.5 mm/s and 1.5 mm/s respectively. Variances between spectra are the result of different coatings
and washing methods.
JK020 was a monodispersed sample with no coating. Mössbauer spectroscopy, seen in Figure 86,
revealed it to be a mix of oxides and possibly metallic iron. Forty percent of the sample had a
hyperfine field of 548 kG while the remaining sixty percent had a hyperfine field of 273 kG.
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Table 7 DLS cumulants results with TEM results (core + shell, agglomerates)
Sample
JK020
JK021
JK022
JK023
JK024
JK025
JK026
JK027
JK028
JK029
JK030
JK031
JK038
JK039
JK040
JK041
JK042
JK043

DLS Diameter
(nm)

PDI

TEM Diameter
(nm)

6580.1
27644.1
6712.9
4531.9
4576.7
1446.7
9463.3
1230.9
5080.1
5218.2
5295.8
1971.6
n/a
n/a
n/a
n/a
n/a
n/a

1.227
3.133
1.118
0.858
0.909
0.335
1.298
0.289
0.948
0.962
0.959
0.429
n/a
n/a
n/a
n/a
n/a
n/a

6-11 nm
n/a
n/a
7-13 nm, 130 nm
n/a
n/a
2-13 nm, 72 nm
3-10 nm, 90 nm
4-14 nm, 280 nm
4-12 nm
4-13 nm, >190 nm
n/a
7-15 nm, >100 nm
7-14 nm, 250 nm
9-16 nm, 735 nm
7-13 nm, 87 nm
6-11 nm, 1545 nm
n/a, >450 nm
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Mössbauer spectroscopy of JK021 (Figure 87) had very low absorption, but the hyperfine field of
481 kG closely resembles Fe2O3. JK023 Mössbauer spectroscopy (Figure 77) portrayed relaxation
not present in other samples with a hyper fine field of 392 kG. It had the longest reaction time and
the largest amount of iron oleate coating which may have contributed to the relaxation.
Mössbauer spectroscopy of JK025 at 6 K, seen in Figure 89, shows a very characteristic Fe2O3
spectrum with a hyperfine field of 494 kG. The sample was coated in only a ferrite shell. It appears
very similar to JK026 and JK027.
Figure 90 shows the fitted Mössbauer spectrum of sample JK026 at 6 K. The spectrum yields a
single Fe3+ site, which implies the sample is composed of Fe2O3. Sample JK026 was coated in a
ferrite shell and the surfactant Brij 30. These results confirm a ferrite shell, but oxidation could
also indicate the failure of the surfactant to protect the nanoparticle.
The Mössbauer spectrum of sample JK027, at 6 K, can be seen in Figure 91. Like sample JK026,
the fitting of this spectra determined the composition to be Fe2O3. This sample did not have a
ferrite coating added post synthesis, so sample JK027 could have oxidized before the Brij 30
surfactant was added. This could also indicate that the surfactant was not a suitable coating to
protect the metallic iron nanoparticles from oxidation. JK028 has very low absorption in
Mössbauer spectroscopy (Figure 92) but still seems to replicate JK025, JK026 and JK027 as it is
all oxide.
Figure 93 is the Mössbauer spectrum of sample JK029 at 6 K. The low absorption and broadening
of the lines hindered a good fit. However, we can confirm that the sample is not metallic iron based
on the hyperfine field. The distance between the peaks seen in Figure 93 is less than the 330 kG
characteristic of metallic iron.
Figure 94 depicts the Mössbauer spectrum of sample JK029 at room temperature. Like Figure 93,
the absorption was very low; however, we can discern further broadening of the lines. This
indicates the sample has a size distribution that includes particles extremely small in size (2.5nm)
(Christensen). This agrees with TEM results of sample JK029.
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Sample JK030 had no coating. Its Mössbauer spectrum (seen in Figure 95) shows a mix of oxides,
where Fe2O3 is the main chemical component. Similar to sample JK029, sample JK030 had very
low absorption. A definite fit of this sample cannot be made due to the absorption and mix of
oxides. Again, this confirms the oxidation of the nanoparticles without coating. The lack of a ferrite
shell resulted in a mix of Fe2+ and Fe3+ oxides. This oxidation mechanism is further described in
Costa 2014 (Costa).
Figure 96 is the Mössbauer spectrum of sample JK031 at 6 K. Sample JK031 was coated only in
the PEG 300 polymer after synthesis and washing of the iron nanoparticles. The spectrum shows
sample JK031 to be a mix of oxides. From this result, it is determined that either oxidation
occurred prior to coating the sample or PEG 300 is not an ideal coating for protecting the
nanoparticle from oxidation.
JK032 had the longest injection time of the Fe(CO)5 and the most iron oleate used for a coating.
Figure 97 is the Mössbauer spectrum for JK032 and has a hyperfine field of 195 kG. This may be
similar to FeC3 which has a hyperfine field of 211 kG. It also has quadrupole splitting not
characteristic of the other thermal decomposition samples.
Figure 98 is the Mössbauer spectrum of JK033 at 6 K. Figure 99 is the Mössbauer spectrum of
JK033 at 293 K. At low temperature the sample resembles the other Fe2O3 spectra with a hyperfine
field of 496 kG. At room temperature the spectrum narrows indicating paramagnetism.
Mössbauer spectroscopy of JK034 was performed at 6 K, 300 K, 300 K with a 0.078 T field and
293 K with a 20 kG field. At low temperature (Figure 100) JK034 was composed of twenty-eight
percent Fe2O3 with a hyperfine field of 495 kG and seventy-two percent with a hyperfine field of
225 kG. There is also relaxation present at low temperature. At higher temperature the field
narrows (Figure 102, Figure 103) indicating paramagnetism. With a 10 kG field applied, seen in
Figure 101, the spectrum sharpens.
The Mössbauer spectrum JK036 at 6 K, seen in Figure 104, resembled JK025, JK026 and other
Fe2O3 samples made using this synthesis method. The sample produced white smoke after the
Fe(CO)5 injection, while other Fe2O3 samples made in synthesis had black, yellow and grey smoke.
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This indicates the smoke produced at synthesis is not correlated to sample composition. A
summary of these findings can be found in Table 8.

Discussion
Small iron nanoparticles <10 nm in size were synthesized by thermal decomposition and encased
with various coatings. The nanoparticles appeared monodispersed under transmission electron
microscopy (TEM). Upon later characterization it was found that all samples were some form of
iron oxide. This could be a result of inadequate protection from oxidation by the coatings, cleaning
methods or annealing and coating application procedures.
A ferrite shell was annealed to the iron nanoparticles and increased stabilization. While the PEG
300 and Brij 30 coatings seemingly did not prevent oxidation, they do provide a biocompatible
surface. Uncoated nanoparticles that were washed to remove the reaction solvents almost fully
oxidized within 4 hours. Storing the iron nanoparticles in their reaction solvent after synthesis
appeared to extend the time before complete oxidation.
The reaction appears incredibly reliable for producing Fe2O3 nanoparticles. Nearly all of the
samples were composed of only Fe2O3 or had some percentage of Fe2O3 present. This is regardless
of size or coatings. It is likely then that the iron core oxidizes completely or partially into Fe 2O3.
The annealing process may also anneal Fe2O3 to the cores; the proportion of oxide shell may be so
great that only the Fe2O3 shell is seen in Mössbauer spectroscopy.
Samples with ferrite shells had the largest size distribution. The annealing process of the ferrite
shell caused the iron nanoparticles to grow which increased size distribution. The longer reaction
time of JK023 (double of all other samples) also increased size distribution. From this it can be
concluded that the heating of the particles past twenty minutes, whether during the synthesis or
coating process, causes particles to grow and varying rates leading to larger size distributions. The
smallest size distribution was seen in the two uncoated samples, JK020 and JK030.
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Table 8 Mössbauer Results of Iron Pentacarbonyl Thermal Decomposition Samples

Sample Temp Field

Site 1
Site 1
Site 1
Isomer
Percentage Hyperfine Shift

JK036
JK034
JK034
JK034
JK034
JK033
JK033
JK032
JK031
JK030
JK029
JK029
JK028
JK027
JK026
JK025
JK023
JK021
JK020

100.00%
28.26%
100.00%
100.00%
100.00%
100.00%
100.00%
78.27%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
39.73%

6K
6K
293 K
300 K
300 K
6K
290 K
290 K
6K
6K
6K
290 K
6K
6K
6K
6K
6K
6K
6K

10 kG
0.078 T

485.52
494.81
0
0
0
495.69
0.00
195.02
469.69
466.92
377.22
329.17
445.76
475.96
491.07
493.61
392.00
481.19
547.87

0.49
0.48
0.27
0.39
0.4
0.46
0.37
0.12
0.29
0.42
0.29
0.88
0.38
0.44
0.44
0.44
0.25
0.52
0.50

Site 1
Site 2
Quadrupole Site 2
Site 2
Isomer
Splitting
Percentage Hyperfine Shift
71.74%

224.52

Site 2
Quadrupole
Splitting

0.42

0.78
21.73%

0.32

-1.09

0.12
0.31
1.27
0.16

0.20
60.27%

273.29

0.40
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Future Work
The surface area of the ferrite and naturally oxidized shell may mask a result of monometallic iron
in Mössbauer spectroscopy. A reduction in size of the ferrite shell may aid the Mössbauer
characterization while still preventing further oxidation. Washing techniques need to be improved
to prevent oxidation while completely removing reaction solvents. An investigation into the ideal
anneal time of the ferrite shell should be performed in attempt to control size distribution of the
nanoparticles.
This type of reaction repeatedly produced oxide results. While this was reliable, it is not the desired
product for the applications targeted in this dissertation. In order to produce iron metal, another
synthesis method will likely need to be utilized. A reduction reaction with a different source of
iron than Chapter II may be ideal.
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Chapter III Appendix
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Figure 53 Iron Oleate/Salt Mixture

Figure 54 Iron Oleate with Added DI Water
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Figure 55 Iron Oleate with Sodium Chloride Removed
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Figure 56 Distillation of Iron Oleate Complex

Figure 57 Thermal Decomposition Synthesis
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Figure 58 Smoke Emitted After Iron Pentacarbonyl Injection
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Figure 59 Residue on Flask Post Synthesis

Figure 60 Magnetic Separation of Sample JK022
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Figure 61 TEM of JK020
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Figure 62 TEM of JK023
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Figure 63 TEM of JK026
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Figure 64 TEM of JK027
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Figure 65 TEM of JK028
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Figure 66 TEM of JK029
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Figure 67 TEM of JK30
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Figure 68 TEM of JK038
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Figure 69 TEM of JK039
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Figure 70 TEM of JK041
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Figure 71 TEM of JK042
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Figure 72 TEM of A) JK040 and B) JK043
B
A

Figure 73 TEM of A) JK040 B) JK043

103

Figure 74 DLS Distribution Results for JK020
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Figure 75 DLS Distribution Results for JK021
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Figure 76 DLS Distribution Results for JK022
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Figure 77 DLS Distribution Results for JK023
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Figure 78 DLS Distribution Results for JK024
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Figure 79 DLS Distribution Results for JK025
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+

Figure 80 DLS Distribution Results for JK026
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Figure 81 DLS Distribution Results for JK027
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Figure 82 DLS Distribution Results for JK028
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Figure 83 DLS Distribution Results for JK029
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Figure 84 DLS Distribution Results for JK030
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Figure 85 DLS Distribution Results for JK031
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Figure 86 Mössbauer Spectrum of JK020 at 6 K

Figure 87 Mössbauer Spectrum of JK021 at 6 K
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Figure 88 Mössbauer Spectrum of JK023 at 6 K

Figure 89 Mössbauer Spectrum of JK025 at 6 K
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Figure 90 Mössbauer Spectrum of JK026 at 6 K

Figure 91 Mössbauer Spectrum of JK027 at 6 K
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Figure 92 Mössbauer Spectrum of JK028 at 6 K

Figure 93 Mössbauer Spectrum of JK029 at 6 K
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Figure 94 Mössbauer Spectrum of JK029 at 290 K

Figure 95 Mössbauer Spectrum of JK030 at 6 K
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Figure 96 Mössbauer Spectrum of JK031 at 6 K

Figure 97 Mössbauer Spectrum of JK032 at 290 K
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Figure 98 Mössbauer Spectrum of JK033 at 6 K

Figure 99 Mössbauer Spectrum of JK033 at 290 K
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Figure 100 Mössbauer Spectrum of JK034 at 6 K

Figure 101 Mössbauer Spectrum of JK034 at 293 K with a 10 kG Field
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Figure 102 Mössbauer Spectrum of JK034 at 300 K

Figure 103 Mössbauer Spectrum of JK034 at 300 K with a 0.078 T Field
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Figure 104 Mössbauer spectrum of JK036 at 6 K
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CHAPTER IV
REDUCTION OF IRON SULFATE
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Introduction
In this chapter, iron nanoparticles were synthesized via a reduction of iron sulfate to further
improve results produced in Chapter II (via reduction of iron chloride). Eleven samples were
created in total. Polyethylene glycol was used as a biocompatible coating. The nanoparticles’ size
was characterized by Transmission Electron Microscopy (TEM) and Dynamic Light Scattering
(DLS) and indicated small nanoparticles plus the presence of agglomerates. Composition was
evaluated with Mössbauer Spectroscopy and appeared to show iron metal and amorphous iron
present. Magnetic Resonance Relaxometry measurements were performed to determine viability
as an MRI contrast agent; T2 relaxation was favored for the nanoparticles.

Methods
Iron Nanoparticle Synthesis
Samples were synthesized at the University of Tennessee Space Institute in Tullahoma, TN.
Samples synthesis was similar to that detailed in Chapter 2 with the exception of the source of iron
and lack of ethanol. Sample synthesis returned to a reduction method because oleic acid and
organic solvents used in the thermal decomposition in Chapter 3 proved difficult, if not impossible,
to completely remove from the particles and solution. This would prevent true biocompatibility
and render the product unfeasible for clinical applications. Iron sulfate was chosen as a
replacement for iron chloride used in Chapter 2.
Samples were prepared by reducing iron (ii) sulfate (Sigma Aldrich) in 30 mL deionized water
with 2.4 g sodium borohydride (Sigma Aldrich) in 30 mL deionized water. Each solution was
taken up into 30 mL syringes through tubing and placed in a dual syringe pump; the pump was set
to a rate of 15 mL per minute. The nanoparticles formed by reacting down the side of a separatory
funnel or condenser column and the neck of a round bottom flask into 20 mL of a coating mixture.
The coating mixture was prepared by stirring 160 µL polyethylene glycol (PEG) 300 (Sigma
Aldrich) and 20 mL deionized water. Deionized water was used to rinse the stir bar of any particles.
A synthesis using the separatory funnel can be seen in Figure 105.
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Exceptions

Two samples, JK050 and JK051, were made using a condenser column in place of the separatory
funnel in an attempt to prevent irreversible agglomerates and oxidation possibly caused by
particles that sometimes became trapped in the separatory funnel. Several modifications were
made to the separatory funnel in an attempt to alleviate this problem which included drilling out
larger openings in the stopcock and using cannulas to force material through the stem of the funnel.
During this time the use of a separatory funnel was questioned. The purpose of the funnel was to
provide a distance for the iron (ii) sulfate and sodium borohydride to react. The longer distance
resulted in smaller particles in previous experiments (Chapter 2), so a 200 mm distillation column
should provide the reaction distance necessary to synthesize small particles.
In addition to length, it was hypothesized the indentions throughout the column may help reduce
agglomerates and the larger diameter would inhibit particles becoming trapped and thereby
uncoated. The indentions helped disseminate agglomerates and the diameter of the column allowed
for all material to react over the same amount of distance. A procedure where all particles were
allowed to react over the same length could prevent coated agglomerates, improve size
distribution, and avoid being trapped and possibly exposed to oxygen in a separatory funnel. This
amended synthesis can be seen in Figure 106.
Sample JK051 was prepared using iron (iii) sulfate instead of iron (ii) sulfate. Unpublished results
from Dr. Johnson’s research group suggest the reduction of Fe3+ resulted in a higher iron metal
content. This sample was prepared using Fe2(SO4)3 instead of FeSO4 and a distillation column to
lengthen the reaction time. This sample was coated in PEG 300 in a nitrogen environment.
Washing and Sample Work-Up

Samples were magnetically separated from the reaction solution. Ethanol was added to crash out
the nanoparticles i.e. force a separation of coated nanoparticles from reaction/washing solution.
The separated solution was pipeted from the sample jar and replaced with deionized water. The
sample jar was left on a magnet to aid in particle separation. This was repeated three times.
Following the third removal of washing solution from particles, some of the concentrated particles
were pipeted out for preparation of Mössbauer Spectroscopy experiments. The remaining sample
was resuspended in deionized water for storage and/or future characterization experiments.
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Transmission Electron Microscopy (TEM)
Transmission electron microscopy (TEM) was performed using a FEI Tecnai Osiris TEM (Figure
107) at Vanderbilt Institute of Nanoscale Science and Engineering. Samples were prepared at The
University of Tennessee Space Institute by diluting the nanoparticles with deionized water until
the solution was barely tinted. A probe sonicator was used to break up agglomerates then a copper
TEM grid was dipped into the solution and dried in air. The grid was mounted to a single-tilt
sample holder (Figure 108) then loaded into the TEM. Samples JK044, JK045, JK045B, JK046,
JK046B, JK047, JK047B, JK048, JK049, JK049B, JK050, and JK051 were characterized using
this technique.
Magnetic Resonance (NMR) Relaxometry
Magnetic Resonance (MR) relaxometry analysis was performed at Vanderbilt University Institute
of Imagining Science, Nashville, TN with the assistance of Dr. Dan Colvin. A Varian MR imaging
system with a 4.7 Tesla field (Figure 109) was used for relaxometry measurements. Samples
JK046, JK047, JK048, JK049 and JK050 were characterized using this technique.
Samples were prepared by extracting the sample after washing and pipetting into disposable NMR
tubes. This step was repeated and each sample was slightly diluted before being added to NMR
tubes. The concentrated and slightly diluted tubes can be seen in Figure 110. The tubes were
stacked in a five by five pattern (Figure 111) before being placed in the scanner. Initial results
deemed the samples too concentrated; the particles fell out of the solution causing false results.
Samples were prepared a second time by diluting in four varying concentrations to the point where
they are barely tinted (much like TEM or DLS). The diluted samples were subjected to 10 seconds
of vortex mixing followed by 60 seconds of sonication using a Fisher Scientific model 100 Sonic
Dismembrator at 7 Watts, seen in Figure 112, before being pipeted into disposable NMR tubes for
analysis (Figure 113). The before and after pictures of these prepared samples can be seen in Figure
114.
Mössbauer Spectroscopy
Sample preparation and spectroscopy measurements took place at the, University of Tennessee
Space Institute Center for Laser Applications. A
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Co source was used for the calibration and

sample measurements. Low temperature measurements were made using a Janis cryostat system
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in conjunction with a SEE Co Mössbauer Spectrometer in a helium environment (Figure 115).
Concentrated samples were pipeted into Mössbauer sample cups after washing. The samples were
dried under nitrogen gas flow then stored in an argon glovebox until characterization via
Mössbauer Spectroscopy.

Results
Transmission Electron Microscopy (TEM)
TEM was performed on samples JK044, JK045, JK045B, JK046, JK046B, JK047, JK047B,
JK048, JK049, JK049B, JK050, and JK051. TEM results show that the diameter of the
nanoparticles for Sample JK044 are 4-39 nm with 400 nm agglomerates (Figure 116). This samples
appears to be completely oxidized and no core shell structure is discernable. This is expected since
no coating was used to protect the nanoparticles from oxidation.
Sample JK045 has apparent core shell structures with cores ranging in size from 4-12 nm and
shells from 11-28. The sample has agglomerates from 35 nm to 800 nm (Figure 117). The sample
has fairly even size distribution.
Sample JK046 has a very even size distribution with agglomerates around 475 nm. It also has a
core shell structure with cores of 2-4 nm and shells of 8-10 nm (Figure 118). Sample JK046B has
a larger size distribution than its coated counterpart. JK046B has cores ranging from 2-8 nm and
shells from 6-24 nm Figure 119. Agglomerates were noted from 218-1384 nm, so it has larger
agglomerates than JK046 as well.
Sample JK047 had the largest size distribution of all samples produced via reduction of iron
sulfate. JK047 had cores of 4-52 nm and shells of 8-68 nm. Agglomerates were observed from
218-1384 nm (Figure 120). Sample JK047B also had a core shell structure, but had a smaller size
distribution and smaller agglomerates than JK047. JK047B had cores of 2-12 nm and shells of 520 nm Figure 121. Agglomerates found in JK047B were under 200 nm.
Sample JK048 had no core shell structures in TEM. The particle diameters ranged from 7-229 nm
with agglomerate of 653-3600 nm (Figure 122). The lack of core shell structures could be due to
particle oxidation after preparation on TEM grid. The grids were stored in air after preparation and
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before characterization.
JK049 had discernable diffraction patterns and very small sample size. It also had noticeable core
shell structures. Cores were measures as 1-2 nm with total diameters of 2-4 nm. The sample had
agglomerates ranging from 103-874 nm Figure 123. JK049B had a larger sample size and greater
size distribution than its coated counterpart. The core shell structure was observed with cores of 415 nm and shells of 5-21 nm. Agglomerates were slightly smaller than JK049 at 275-568 nm Figure
124.
JK050 had a very even size distribution and a core shell structure. Nanoparticles were very small.
Cores were measures at 2-3 nm and total diameters at 3-5 nm (Figure 125). A large agglomerate
was measures at 918 nm. The improved size distribution could be due to the use of a distillation
column in place of a separatory funnel. The column prevented material from becoming trapped in
the funnel, so all material traveled the same distance in roughly the same time.
JK051 also had good size distribution, but smaller agglomerates was the most notable feature.
Agglomerates were measures at 76 nm. This was the smallest agglomerates of all the samples.
Core shell structures were present: cores varied from 2-5 nm with shells at 5-14 nm. (Figure 126).
A summary of these TEM results can be seen in Error! Reference source not found..
Magnetic Resonance Relaxometry
As mentioned previously, the initial samples were too concentrated and resulted in the particles
separating from the water solution. The relaxometry measurements demonstrating this can be seen
in Figure 127. The second batch of samples prepared with a sonicator gave trustworthy results as
seen in Figure 128.

131

Table 10 details the results for the first experiment and Table 11 presents results of the diluted and
sonicated samples. Samples that were too concentrated and yielded no result are represented as
n/a; this occurred to nearly every sample at the original concentration. In the second set of results
no noticeable correlation of either concentration or iron content could be seen with the T2 or T1
relaxation times. The results do confirm the preference of T2 relaxation for these samples.

Table 9 Summary of TEM Results
Sample
JK044
JK045
JK046
JK046B
JK047
JK047B
JK048
JK049
JK049B
JK050
JK051

Core Diameter (nm)
4-9
2-4
2-8
4 - 52
2 - 12
1-2
4 - 15
2-3
2-5

Total Diameter (nm)
4 - 39
11 - 28
8 - 10
6 - 24
8 - 68
5 - 20
7 - 29
2-4
8 - 21
3-5
5 - 14

Agglomerates (nm)
400
35 - 800
475
218 - 1384
195
430
653 - 3600
103 - 874
275 - 568
918
76
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Table 10 Relaxometry Results of Concentrated Samples
Sample
JK046
JK046
JK047
JK047
JK047B
JK047B
JK048
JK048
JK049
JK049
JK049B
JK049B
JK050
JK050
DI water

Concentration
normal
dilute
normal
dilute
normal
dilute
normal
dilute
normal
dilute
normal
dilute
normal
dilute
normal

T2 (ms)
118.7
176.8
n/a
110.3
70.3
73
n/a
162.7
401.6
376.2
n/a
149
365.2
587.7
985

T1 (ms)
1388
1386
n/a
1242.6
1058.5
1125.3
n/a
1411.3
1527.2
1496
n/a
1225.3
1464.6
1550.8
1643.6

% Fe
metal
59.84
59.48
45.53
45.53
44.16
44.16
41.07
41.07
50.98
50.98
22.70
22.70
52.41
52.41
0.00

Table 11 Relaxometry Value of Varying Concentrations
Sample
JK047
JK047
JK047
JK047
JK047B
JK047B
JK047B
JK047B
JK048
JK048
JK048
JK048

Concentration
conc 1
conc 2
conc 3
conc 4
conc 1
conc 2
conc 3
conc 4
conc 1
conc 2
conc 3
conc 4

T2 (ms)
1173.6
1020.1
1119
1125.3
1175
1155.1
1180.9
1139.5
1101.5
1133.6
1107.7
1042.9

T1 (ms)
2847.7
2848.3
2889.1
2917.4
2878.9
2873.2
2907.9
2888.9
2884.3
2882.9
2900.8
2848

% Fe
metal
45.53
45.53
45.53
45.53
44.16
44.16
44.16
44.16
41.07
41.07
41.07
41.07
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Mössbauer Spectroscopy
Mössbauer spectroscopy was performed at varying temperatures. A field was applied to some
samples. Analysis was performed using Mössbauer GenFit Software (R.S. Preston and D.E.
Brown) to plot and fit spectra. Mössbauer spectroscopy consistently showed amorphous iron
present throughout all samples made by reducing iron sulfate. Amorphous iron typically has a
hyperfine field of 285 kG. This is consistent with spectra seen in Chapter IV Appendix.
Despite the presence of amorphous iron, all samples were composed of some percentage of
metallic iron (Table 12). Metallic iron has a hyperfine field of 330 kG. This was seen in all spectra
analyzed. Some samples did also contain iron oxide. The hyperfine field of iron oxide is around
520 kG; this was observed in JK044, JK047B, and JK049. The presence of oxide was expected in
JK047B and JK044 since they have no coating. Sample JK044 was not synthesized in an inert
environment and had the largest amount of oxide present.

134

Table 12 Mossbauer Results of Iron Sulfate Reduction Samples
Site 1
Field Percentage

Site 1
Site 1
Isomer
Hyperfine Shift

Site 2
Site 2
Site 2
Isomer
Percentage Hyperfine Shift

Site 3
Percentage

Site 3
Hyperfin
e

Site 3
Isomer
Shift

11.57%
19.45%

0.0
0.0

1.31
1.16

18.71%
13.41%
14.29%
7.83%
1.69%

499.5
0.0
493.6
0.0
500.0

0.45
0.34
0.54
0.32
0.00

Sample

Temp

JK044
JK044
JK045
JK045

6K
293 K
6K
293 K

56.82%
31.89%
100.00%
100.00%

506.9
443.8
335.9
308.6

0.44
0.55
0.10
0.08

31.61%
30.04%

341.7
330.7

0.16
0.00

JK046
JK046

6K
293 K

59.84%
32.43%

339.1
335.1

0.11
0.00

40.16%
67.57%

282.8
264.7

0.20
0.07

JK046
JK047
JK047
JK047B
JK047B
JK048

293 K
6K
293 K
6K
293 K
6K

28.02%
45.53%
28.89%
44.16%
25.64%
41.07%

326.3
341.9
266.1
342.1
334.8
342.0

0.00
0.16
0.08
0.11
0.00
0.11

71.98%
54.47%
71.11%
55.84%
74.36%
58.93%

253.1
289.6
332.56
284.85
249.9
284.4

0.07
0.19
0.00
0.18
0.00
0.18

JK048
JK049
JK049
JK049B
JK049B
JK050

293 K
6K
293 K
6K
293 K
6K

27.94%
50.98%
40.50%
35.04%
22.70%
52.41%

332.3
341.4
331.6
341.3
331.7
342.3

0.00
0.11
0.00
0.11
0.00
0.11

72.06%
30.31%
46.09%
50.67%
69.47%
45.90%

263.5
286.9
259.8
277.9
251.0
285.9

0.04
0.22
0.00
0.20
0.06
0.21

JK050
JK051

293 K
6K

33.71%
40.07%

331.8
344.7

0.00
0.11

66.29%
59.93%

235.1
289.2

0.01
0.18

10
kG
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Discussion
These samples were made in a similar fashion as the samples in Chapter II. Iron sulfate was used
instead of iron chloride. A distillation column was used to try and help break up agglomerates and
encourage coating. Only polyethylene glycol was used as a coating in this chapter compared to
several coatings in previous chapters, and only deionized water was used as a solvent (ethanol was
used with deionized water in Chapter II).
The exchange of a separatory funnel for condenser column in sample synthesis did not appear to
affect the composition of the nanoparticles. TEM of samples made with both the separatory funnel
and distillation column showed similar size. The size distribution of samples made with the column
were slightly better than those with the separatory funnel, and more coated material was produced
using the column. It was common with the separatory funnel to have half of the reaction product
not make it into the coating solution; these samples presented with more oxide than their coated
counterparts. It can be concluded that the distillation column helped ensure every nanoparticle was
coated resulting in more coated nanoparticles and possibly helped with size distribution by
providing a consistent reaction length and time.
NMR results suggest this synthesis would be favored in applications of hyperthermia as the T2
was low. Mössbauer determined iron metal was present in all samples in addition to amorphous
iron. Amorphous iron was not present in the reduction of iron chloride in Chapter II.
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Chapter IV Appendix

Figure 105 Synthesis of iron nanoparticles with separatory funnel
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Figure 106 Synthesis of iron nanoparticles with distillation column
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Figure 107 FEI Tecnai Osiris TEM at VINSE

Figure 108 TEM single tilt sample holder
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Figure 109 Varian MR Imaging System
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Figure 110 Concentrated samples in NMR tubes

Figure 111 Placement of NMR tubes
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Figure 112 Probe Sonicator at Vanderbilt University

Figure 113 Prepared NMR Tubes of Varying Concentrations
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A

B

Figure 114 A) Before and B) After Probe Sonication of Sample JK048

Figure 115 Mössbauer Spectrometer Setup

143

Figure 116 TEM of JK044

144

Figure 117 TEM of JK045

145

Figure 118 TEM of JK046

146

Figure 119 TEM of JK046B

147

Figure 120 TEM of JK047
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Figure 121 TEM of JK047B
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Figure 122 TEM of JK048
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Figure 123 TEM of JK049
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Figure 124 TEM of JK049B
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Figure 125 TEM of JK050
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Figure 126 TEM of JK051
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Figure 127 Original T2 and T1 Map

Figure 128 T2 and T1 Map of Varying Concentrations
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Figure 129 Mӧssbauer Spectrum of JK044 at 5K

Figure 130 Mӧssbauer Spectrum of JK044 at 293K
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Figure 131 Mössbauer Spectrum of JK045 at 5K

Figure 132 Mӧssbauer Spectrum of JK045 at 293K
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Figure 133 Mössbauer Spectrum of JK046 at 5 K

Figure 134 Mössbauer Spectrum of JK046 at 293 K
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Figure 135 Mössbauer Spectrum of JK046 at 293 K in 10 kG Field

Figure 136 Mӧssbauer Spectrum of JK047 at 5K
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Figure 137 Mӧssbauer Spectrum of JK047 at 293K

Figure 138 Mössbauer Spectrum of JK047B at 5K
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Figure 139 Mössbauer Spectrum of JK047B at 293K

Figure 140 Mössbauer Spectrum of JK047B at 5K after One Week in Air
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Figure 141 Mössbauer Spectrum of JK047B after Two Weeks in Air

Figure 142 Mössbauer Spectrum of JK047B at 6K after Three Weeks in Air
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Figure 143 Mössbauer Spectrum of JK047B at 6K after Four Weeks in Air

Figure 144 Mössbauer Spectrum of JK047B at 6K after Five Weeks in Air
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Figure 145 Mössbauer Spectrum of JK047B at 293K after Five Weeks in Air

Figure 146 Mössbauer Spectrum of JK048 at 5K

164

Figure 147 Mössbauer Spectrum of JK048 at 293K

Figure 148 Mössbauer Spectrum of JK049 at 6K
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Figure 149 Mössbauer Spectrum of JK049 at 293K

Figure 150 Mössbauer Spectrum of JK049B at 6K
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Figure 151 Mössbauer Spectrum of JK049B at 293K

Figure 152 Mössbauer Spectrum of JK050 at 6K
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Figure 153 Mössbauer Spectrum of JK050 at 293K

Figure 154 Mössbauer Spectrum of JK051 at 6K
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CHAPTER V
CONCLUSIONS
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The aim of this research is to develop iron nanoparticles suitable for use as MRI contrast agents,
for enhancement of LITT, and to combine these capabilities for MRgLITT. Synthesis methods
employed are reduction and thermal decomposition of varying iron reactants. Several
biocompatible coatings were investigated to determine their performance as a protective layer.
Characterization techniques used include DLS, TEM, Mössbauer Spectroscopy, NMR, and
cytotoxicity. The main target of this biomedical application is to further the diagnosis and
treatment of brain cancer, specifically glioblastoma multiforme.

Iron Chloride Reduction
Reduction of iron (ii) chloride resulted in metal iron and iron oxide nanoparticles. Coatings
attributed to agglomerates. Brij coated nanoparticles were deemed safe in cytotoxicity studies at
low concentrations. A longer reaction length produced smaller nanoparticles. Iron metal
nanoparticles had not oxidized completely after three years of storage in air.

Iron Pentacarbonyl Thermal Decomposition
Thermal decomposition in organics produced iron oxide nanoparticles with an iron metal core.
The reaction proved to be very reproducible. Both ferrite and polymer coatings were
investigated. Polymer coatings, such as polyethylene glycol and Brij, protected the ore from
further oxidation. Nanoparticles that had ferrite shells annealed had larger size distributions than
those without; this is due to further growing the nanoparticles at high temperatures during the
annealing process.

Iron Sulfate Reduction
Iron sulfate reductions created metal and amorphous iron nanoparticles. Utilization of a probe
sonicator drastically improved accuracy of characterization. The use of a distillation column
provided the desired length to achieve small nanoparticles and reduced agglomerates during
synthesis. The column improved size distribution and produced a larger yield of coated sample.

Outlook
In the future, synthesis of iron nanoparticles using a reduction reaction could be improved by
utilizing a probe sonicator during synthesis and coating. The addition of a sonicator during
170

synthesis could increase temperatures and cause oxidation, so temperature should be monitored
throughout.
Examining the electrochemistry of the reaction could help minimize oxidation. The pH of
nanoparticle samples should be evaluated. Utilizing a Pourbaix diagram for iron could improve
the prevention of oxidation after synthesis by altering or maintaining pH.
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Table 13 Synthesis Method and Coating of All Samples
Sample

Synthesis Type

Coating(s)

Reaction Solvent

JK001

FeCl2 reduction with separatory funnel

Brij 30

Ethanol

JK002

FeCl2 reduction

Brij 30

Ethanol

JK003

FeCl2 reduction with separatory funnel

Brij 30

Ethanol

JK004

FeCl2 reduction

Brij 30

Ethanol

JK005

FeCl2 reduction

Brij 30

Ethanol

JK006

FeCl2 reduction with separatory funnel

Brij 30

Ethanol

JK007

FeCl2 reduction with separatory funnel

PEG 600 diacid

Ethanol

JK009

FeCl2 reduction with separatory funnel

none

Ethanol

JK010

FeCl2 reduction by pouring

Brij 30

Ethanol

JK011

FeCl2 reduction with separatory funnel

PEG 600 diacid

Ethanol

JK012

FeCl2 reduction with separatory funnel

PEG 600 diacid

Ethanol

JK018
JK019

Reduction with funnels into flask
Reduction with funnels into flask

Brij 30
Brij 30

Ethanol
Ethanol

JK020

Thermal decomposition 1.4 mL Fe(CO)5

none

ODE/OY

JK021

Thermal decomposition 1.4 mL Fe(CO)5

0.4 mL iron oleate

ODE/OY

JK022

Thermal decomposition 1.4 mL Fe(CO)5

0.4 mL iron oleate

ODE/OY

JK023

Thermal decomposition 1.4 mL Fe(CO)5

none

ODE/OY

JK024

Thermal decomposition 1.4 mL Fe(CO)5

none

ODE/OY

JK025

Thermal decomposition 2.8 mL Fe(CO)5

0.4 mL iron oleate

ODE/OY

JK026

Thermal decomposition 2.8 mL Fe(CO)5

0.4 mL iron oleate + Brij 30

ODE/OY

JK027

Thermal decomposition 2.4 mL Fe(CO)5

Brij 30

ODE/OY

JK028

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate + PEG 300

ODE/OY

JK029

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK030

Thermal decomposition 2.4 mL Fe(CO)5

none

ODE/OY

JK031

Thermal decomposition 2.4 mL Fe(CO)5

PEG 300

ODE/OY

JK032

Thermal decomposition 7.2 mL Fe(CO)5

0.6 mL iron oleate

ODE/OY

JK033

Thermal decomposition 7.2 mL Fe(CO)5

0.3 mL iron oleate

ODE/OY

JK034

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK035

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK036

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK038

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK039

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK040

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK041

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK042

Thermal decomposition 2.4 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY

JK043

Thermal decomposition 2.3 mL Fe(CO)5

0.1 mL iron oleate

ODE/OY
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Table 13 Continued
Sample
Synthesis Type

Coating

Reaction Solvent

JK044

FeSO4 reduction with separatory funnel

none

DI water

JK045

FeSO4 reduction with separatory funnel

PEG 300

DI water

JK046/46B

FeSO4 reduction with separatory funnel

PEG 300/none

DI water

JK047/47B

FeSO4 reduction with separatory funnel

PEG 300/none

DI water

JK048

FeSO4 reduction with separatory funnel

PEG 300

DI water

JK049/49B

FeSO4 reduction with separatory funnel

PEG 300/none

DI water

JK050

FeSO4 reduction with distillation column

PEG 300

DI water

JK051

FeSO4 reduction with distillation column

PEG 300

DI water
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